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Abstract
Terpene synthases/cyclases yield core structures of some of the most valuable bioactive molecules, such
as artemisinin and paclitaxel. A detailed understanding of structure–function relationship of terpene
synthases/cyclases delineates the evolutionary relationship between different enzymes and molecular
basis of their strategies to direct and manipulate carbocation intermdiates throughout the catalysis
trajectory.
Using Aspergillus terreus aristolochene synthase and Streptomyces citricolor germacradiene-4-ol
synthase, both of which are high-fidelity cyclases, as model systems, we have provided structural
evidence showing that the pyrophosphate group is responsible for carrying out general base–general acid
chemistry throughout the carbocation cascade. We also show that despite the highly reactive nature of
carbocation intermediates, terpene cyclases accurately guide active site water molecules that are
tethered by surrounding residues to serve as a part of the enzymatic template or are catalytically
activated at the right time to hydroxylate the final carbocation intermediate.
Phomopsis amygdali fusicoccadiene synthase (PaFS) is the first identified bifunctional diterpene
synthase that carries out tandem elongation and cyclization reactions. We have shown that cyclization
activity of the bona fide substrate geranylgeranyl diphosphate (GGPP) by the full-length enzyme is subject
to allosteric regulation, and hexamerization of PaFS driven by the elongation domain creates proximity
effects that accelerate product flux by 2 fold. We also present structural studies that shed light on its
catalytic mechanism and reveal its evolutionary relationships between bifunctional diterpene synthases
and similar sesterterpene synthases.
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ABSTRACT
TERPENE SYNTHASES: ONE FOLD, MANY PRODUCTS
Mengbin Chen
Dr. David W. Christianson
Terpene synthases/cyclases yield core structures of some of the most valuable bioactive
molecules, such as artemisinin and paclitaxel. A detailed understanding of structure–function
relationship of terpene synthases/cyclases delineates the evolutionary relationship between
different enzymes and molecular basis of their strategies to direct and manipulate carbocation
intermdiates throughout the catalysis trajectory.
Using Aspergillus terreus aristolochene synthase and Streptomyces citricolor
germacradiene-4-ol synthase, both of which are high-fidelity cyclases, as model systems, we have
provided structural evidence showing that the pyrophosphate group is responsible for carrying out
general base–general acid chemistry throughout the carbocation cascade. We also show that
despite the highly reactive nature of carbocation intermediates, terpene cyclases accurately guide
active site water molecules that are tethered by surrounding residues to serve as a part of the
enzymatic template or are catalytically activated at the right time to hydroxylate the final
carbocation intermediate.
Phomopsis amygdali fusicoccadiene synthase (PaFS) is the first identified bifunctional
diterpene synthase that carries out tandem elongation and cyclization reactions. We have shown
that cyclization activity of the bona fide substrate geranylgeranyl diphosphate (GGPP) by the fulllength enzyme is subject to allosteric regulation, and hexamerization of PaFS driven by the
elongation domain creates proximity effects that accelerate product flux by 2 fold. We also
present structural studies that shed light on its catalytic mechanism and reveal its evolutionary
relationships between bifunctional diterpene synthases and similar sesterterpene synthases.
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CHAPTER 1: Introduction
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Natural Products
Natural products have been used since the dawn of time as fragrances, insect attractants
and repellents, and medicines. Primary metabolites and secondary metabolites in bacteria, fungi,
and plants, together constitute natural products, which are used by the native organism to regulate
their own biology as well as mediate their interactions with the environment (Bennett and
Wallsgrove, 1994; Yim and Wang, 2007). While primary metabolites are indispensable for the
survival of the organism, secondary metabolites are synthesized to boost the robustness of the
organism. Using primary metabolites as building blocks, secondary metabolites, such as penicillin,
paclitaxel, and erythromycin A (Figure 1.1), are especially intriguing due to their wide spectrum
of bioactivities and can be used as antimicrobials and antitumor agents (Berdy, 2005; Cortes et al.,
1990; Dewick, 2001; Muller et al., 1991; Smith et al., 1990; Stanzak et al., 1986; Weber and
Losick, 1988; Wildung and Croteau, 1996). Considering that primary and secondary metabolites
play fundamentally different roles in their respective biological contexts, their distribution and
concentrations are significantly different and organism-specific (Pichersky and Gang, 2000). In
contrast to primary metabolism, secondary metabolism is turned on by external physical or
chemical elicitors; and thus, the yield of corresponding metabolites is generally low.
Traditionally, natural products are directly extracted from the source organism or
produced by total synthesis. The high costs and negative environmental outcome associated with
this process motivate the development of novel methods to meet the demand for natural products.
Gutaf Komppa’s industrial synthesis of camphor via semi-synthesis from pinene marked the
beginning of synthetic biology, in which scientists turned to biology for synthetic building blocks
that are inaccessible by conventional chemical synthesis. Thanks to the buildup of knowledge of
biosynthetic pathways across all kingdoms of life and progress in gene-manipulation technologies,
some compounds that were once scarce can now be produced on a large scale in an
2

environmentally friendly fashion (Ro et al., 2006). In turn, the large-scale production of natural
products accentuates research on individual biosynthetic enzymes to better understand structurefunction relationships.
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Figure 1.1. Acetyl-CoA is the central building block of numerous natural products. Glycolysis is
the primary metabolism that converts glucose to pyruvate. One of the pyruvate downstream
products is acetyl-CoA, a building block of myriad secondary metabolites that are medicinally
important, such as paclitaxel, penicillin G, and erythromycin A.
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Terpenoids
The 2015 Noble Prize brought artemisinin, one of the most renowned members in
terpenoids, under spotlight again. Artemisinin is a sesquiterpene trioxane lactone whose
endoperoxide bridge (C-O-O-C) is essential to meet dual challenges posed by emerging drug
resistance and the rapid progression of malaria (Figure 1.2) (Meshnick et al., 1996; Wang et al.,
2010). Despite its widespread use for combating against malaria for decades, the mode of action
of artemisinin is yet to be fully elucidated, possibly due to its scaffold complexity and multiple
functional groups conferring binding promiscuity to a variety of physiologically relevant targets.
Pandev and colleagues have shown that artemisinin interferes with plasmodial hemoglobin
pathway by inhibiting heme polymerization (Pandev et al., 1999). Wang and colleagues used an
artemisinin-based alkyne probe to pull down its targets including various components of primary
metabolism in Plasmodium falciparum and provided supporting evidences that artemisinin is
activated by heme (Wang et al., 2015). Recently, Mbengue and colleagues demonstrated that the
antimalarial properties of artemisinin may derive from its potent inhibition of Plasmodium
falciparum phosphatidylinositol-3-kinase (PfPI3K) (Mbengue et al., 2015).
Such structural and functional complexity originates from a single five-carbon building
unit, isopentenyl diphosphate (IPP), which can be traced back to the primary metabolite acetylCoA. IPP can be isomerized to dimethylallyl diphosphate (DMAPP). Prenyl diphosphate
synthases condenses 1 DMAPP and several IPP molecules in a head-to-tail fashion, giving rise to
prenyl diphosphates (Figure 1.2). Nonetheless, the number of carbon atoms of prenyl
diphosphates are not always multiples of 5. For instance, the extra carbon atom of 11-carbon 2methyl geranyl diphosphate (2M-GPP) is installed by a S-adenosyl-l-methionine (SAM)dependent methyltransferase to GPP in Streptomyces coelicolor A3(2) (Bentley and Meganathan,
1981; Komatsu et al., 2008; Wang and Cane, 2008). Subsequently, terpene cyclases bind these
5

linear prenyl diphosphate substrates with a precisely controlled conformation prior to initiation of
a cyclization cascade that proceeds through several carbocation intermediates leading to the
formation of final product(s) with multiple rings and stereocenters (Abe et al., 1993; Cane, 1985;
Cane, 1990; Christianson, 2006; Lesburg et al., 1998; Wendt et al., 2000). Downstream tailoring
enzymes, such as cytochrome P450s and methyltransferases (Hashimoto et al., 2009; Minami et
al., 2009), incorporate modifications to the carbon skeletons, thus conferring a broad spectrum of
biological activities to the final product(s) out of this biosynthetic pathway (Clardy and Walsh,
2004; Pichersky et al., 2006).
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Figure 1.2. Artemisinin biosynthesis in Artemisia annua. Primary metabolite acetyl-CoA is
central to artemisinin biosynthesis. Acetyl-CoA is converted to IPP via multiple steps, and IPP
can be isomerized to dimethylallyl diphosphate by IPP isomerase. FPP synthase condenses 1 unit
of DMAPP and 2 units of IPP into FPP, which is subsequently consumed by amorphadiene
synthase that generates the hydrocarbon skeleton of artemisinin. Downstream motifying enzymes
install a myriad of functional groups that confer bioactivities to the final product artemisinin.
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Terpene synthases
Traditionally, terpene cyclases are divided into 2 classes based on their distinct catalytic
mechanisms: Class I terpene cyclases recruits 3 Mg2+ ions to trigger ionization of the diphosphate
group to initiate catalysis (Figure 1.3a&b); Class II enzymes, on the other hand, utilizes a strictly
conserved aspartate residue to protonate the terminal alkene group of the substrate to initiate the
carbocation cascade (Figure 1.3c) (Wendt et al., 1997). However, recent findings of novel terpene
cyclases that use non-canonical strategies to initiate catalysis illustrate that nature’s repertoire of
biosynthetic principles are far more diverse than previously thought (Figure 1.3d) (CarterFranklin et al., 2003; Cheng and Li, 2014). Although different classes of terpene cyclases adopt
different strategies in initiating catalysis, all play a critical role as a template for catalysis
(Christianson, 2006; Christianson, 2008). For canonical enzymatic terpene cyclizations and some
non-canonical ones (Carter-Franklin et al., 2003; Hillwig et al., 2013), the active site residues fold
the isoprenoid chain in a productive conformation and direct carbocation intermediates along the
correct catalytic trajectory so that ring structure and stereochemistry of product(s) are accurately
controlled for downstream modifications by tailoring enzymes. This thesis focuses on canonical
terpene cyclization; noncanonical catalysis has been reviewed elsewhere (Baunach et al., 2014).
The ancestors of Class I terpene cyclases are considered to be prenyl diphosphate
synthases, both of which share the same α-helical fold, designated as the “α domain”. There are 2
metal binding motifs flanking the upper side of the active site: while the sequence of the first
metal binding motif is DDXXD/E and is strictly conserved in both enzyme groups, the second
metal binding motif diverged from DDXXD in prenyl diphosphate synthases to NSE/DTE in
class I terpene cyclases (Lesburg et al., 1997; Tarshis et al., 1994). The binding of 3 divalent
metal ions and the diphosphate group of the substrate brings 2 metal binding motifs together and
thus enforces a fully closed active site conformation (Figure 1.3a). This ensures that carbocation
8

intermediates will not be prematurely quenched by bulk solvent. Mechanistically, prenyl
diphosphate synthases couple DMAPP and IPP in head-to-tail fashion by positioning the alkene
group of IPP perfectly so that it attacks the carbocation center of dimethylallyl moiety after the
diphosphate group leaves; Class I terpene cyclases form new carbon-carbon bond by folding the
isoprenoid chain such that the carbocation center is in proximity to the terminal alkene for
subsequent electrophilic attack to take place (Pronin and Shenvi, 2012).
Represented by squalene-hopene cyclase (Wendt et al., 199), class II terpene cyclases
adopt a different fold, designated as “βγ domains” (Figure 1.4). While active sites of class I
terpene synthases/cyclases are cavities in the α-helix bundle, active sites of class II terpene
cyclases reside at the interface between 2 domains, where there is more space (Wendt et al., 1997;
Zhou et al., 2012). This demonstrates a strategy of dividing workload toward different substrates
by different classes of enzymes, since substrates of class II terpene cyclases are generally longer
than those of class I terpene synthases/cyclases. The signature catalytic motif of class II terpene
cyclases is DXDD, and the middle aspartate residue is responsible for activating the substrate via
protonation (Wendt et al., 1997; Peters and Croteau, 2002; Zhou et al., 2012) (Figure 1.3c). In
spite of multiple aspartate residues present, class II terpene cyclases do not require divalent metal
ions for catalysis, but they presumably facilitate substrate binding (Peters and Croteau, 2002). On
the other hand, high concentration of Mg2+ ions are shown to be inhibitory to class II terpene
cyclases. To solve this conundrum, the enzyme utilizes a conserved histidine residue that forms a
salt bridge with the middle aspartate residue so that the aspartate residue is not only inaccessible
to Mg2+ ions but is activated for protonating the alkene group as well (Merkofer et al., 1999;
Wendt et al., 1997; Zhou et al., 2012).
Given that class I and class II cyclases use different strategies to initiate carbocation
cyclization cascades and adopt different domain architecture, it is straightforward for nature to
9

mix and match these two entities together. Abietadiene synthase from Abies grandis and entcopalyl diphosphate synthase from fungus Phaeosphaeria sp. L487 adopt αβγ domain
architecture with both class I and class II active sites functional and thus capable of catalyzing
consecutive reactions (Kawaide et al., 2000; Zhou et al., 2012). With the same three-domain
structure, Taxus brevifolia taxadiene synthase and Arabidopsis thaliana ent-copalyl diphosphate
synthase have non-functional vestigial class II and class I active sites, respectively (Figure 1.4)
(Koksal et al., 2011; Koksal et al., 2011). Therefore, αβγ domain architecture can serve as the
missing link connecting α(β) with βγ domain architecture. Moreover, manually fusing
αβγ domains from separate ones can increase the product flux by 4-fold, demonstrating the
proximity effect enabled by high local concentration of the product of the first reaction which
serves as the substrate of the second reaction (Su et al., 2016). Geosmin synthase, on the other
hand, is notable in fusing two α domains on one polypeptide chain carrying out successive
catalysis but of significantly different nature: Its N-terminal domain adopts all canonical class I
sesquiterpene cyclase feature cyclizing FPP to germacradienol, and the C-terminal domain
fragments germacradienol into geosmin and acetone (Harris et al., 2015; Jiang et al., 2006; Jiang
et al., 2007). A high sequence identity of 36% between 2 domains suggests the occurance of gene
duplication. Subsequent divergence from the duplicated domain confers novel activity to the
newly emerged synthase, leading to an increase in the molecular complexity of the entire
biosynthetic pathway.
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terpene cyclases, its cyclization strategy seems akin to the canonical ones by triggering
cyclization via introducing a carbocation center.
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Figure 1.4. Genesis and evolution of terpene cyclases. a) Genes for ancestral βγ‐domain proteins
(like SHC; PDB ID: 3SQC) fuse with genes for ancestral α‐domain species like FPPS (PDB ID:
1ZW5); b) a diterpene cyclase with three helical domains (αβγ) is generated. c) Orange shading
indicates the close proximity (ca. 2.5 Å) of the SHC C terminus and the FPPS N terminus (from
an α/αβ/βγ FPPS/EAS/SHC alignment). d) Structure of an actual diterpene cyclase, taxadiene
synthase (PDB ID: 3P5P). e) Loss of the γ domain yields an αβ protein, for example, the
sesquiterpene cyclase isoprene synthase (PDB ID: 3N0F). f) Further loss of the β domain yields
other cyclases such as pentalenene synthase (PDB ID: 1PS1), an α‐domain cyclase. Note the
N‐terminal helix (magenta) portion is conserved in αβ, βγ, and αβγ proteins and is known to be
13

required for activity. Reprinted with permission from the publisher: John Wiley and Sons.
Reprinted with permission from E. Oldfield and F.-Y. Lin. Terpene biosynthesis: Modularity
rules. Angewandte Chemie International Edition, 2011, 51, 1124-1137. Copyright 2011 John
Wiley and Sons.
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Plasticity of Terpene Cyclases and the Biological Implications
Active site permissiveness is critical in determining the number of products generated by
the cyclase, which is related to the function of the cyclase in metabolism and how this
metabolism affects the survival and robustness of the organism (Copley, 2003; Christianson,
2007; Fischbach and Clardy, 2007; Kramer and Abraham, 2012; Nobeli et al., 2009). For
example, lanosterol synthase is a high-fidelity enzyme that catalyzes the exclusive formation of
the C30 steroid lanosterol from (S)-2,3-oxidosqualene in cholesterol biosynthesis (Abe et al.,
1993; Corey et al., 1997). In stark contrast, γ-humulene synthase is a promiscuous enzyme
involved in secondary metabolism of Abies grandis and generates 52 products from the C15
substrate farnesyl diphosphate (Steele et al., 1998). The function of producing a wide array of
products by a promiscuous cyclase is two-fold: first, some if not all existing compounds can
promote the fitness of an organism to live in a less benign environment; Second, the cyclase is in
the middle of generating new molecule(s) that respond(s) to new environmental cues (Firn and
Jones, 2000; Firn and Jones, 2003). Once one product or a mixture of products is/are identified to
be useful, evolution pressure can gradually amplify its/their production so that the organism
becomes well established in the ecosystem. For instance, Gonzalez and colleagues have shown
that a single amino acid residue switch can convert a (1,11)-cyclization plant sesquiterpene
cyclase into a (1,10)-cyclization cyclase, supporting the proposal that (1,10) cyclase may have
evolved from a promiscuous (1,11) plant sesquiterpene cyclase (Gonzalez et al., 2014;
Thulasiram et al., 2007). Nonetheless, even if a compound proves to be advantageous to the
organism, the compound may not be the exclusive product of the corresponding biosynthetic
pathway, indicating that the selection pressure is not posed on pathway fidelity. Considering that
bioactive metabolites do not require high abundance to function, shunt products are minuscule so
higher fidelity would not bestow evolution advantages (Fischbach and Clardy, 2007).
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So what is the molecular basis of product fidelity and promiscuity in terpene cyclases?
Apart from the active site contour that enforces the substrate to adopt a product-like conformation
in a cavity whose volume is slightly larger than that of the bona fide substrate (Koksal et al.,
2011), electrostatic interactions exerted by the diphosphate group play a role in guiding catalysis
and governing product diversity (Major and Weitman, 2012; Vedula et al., 2005; Zhou and
Peters, 2011). Extending this thought further, if product outcome is encoded in the gene sequence,
which can be made available through genome sequencing efforts, can we rationally predict the
product profile of terpene cyclases? Although our knowledge regarding this subject is still
limited, recent endeavors to predict the function of polyprenyl diphosphate synthases combining
protein-ligand docking computation and phylogenetic analyses demonstrate the feasibility of
mapping out functions of unknown enzymes in a protein family (Wallrapp et al., 2013). A more
general approach to quickly and accurately annotate terpene cyclase function from molecular and
cellular perspective will require a full mechanistic understanding of how these enzymes exert
accurate control over catalysis and the underlying evolutionary relationship.
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Focus of Thesis
Aristolochene synthase, a metal-dependent sesquiterpene cyclase from Aspergillus
terreus, catalyzes the ionization-dependent cyclization of farnesyl diphosphate (FPP) to form the
bicyclic eremophilane (+)-aristolochene with perfect structural and stereochemical precision.
Here, we report the X-ray crystal structure of aristolochene synthase complexed with three Mg2+
ions and the unreactive substrate analogue farnesyl-S-thiolodiphosphate (FSPP), showing that the
substrate diphosphate group is anchored by metal coordination and hydrogen bond interactions
identical to those previously observed in the complex with three Mg2+ ions and inorganic
pyrophosphate (PPi). Moreover, the binding conformation of FSPP mimics that expected for
productively bound FPP, with the exception of the precise alignment of the C-S bond with regard
to the C10-C11 π system that would be required for C1-C10 bond formation in the first step of
catalysis. We also report crystal structures of aristolochene synthase complexed with Mg2+3-PPi
and ammonium or iminium analogues of bicyclic carbocation intermediates proposed for the
natural cyclization cascade. Various binding orientations are observed for these bicyclic
analogues, and these orientations appear to be driven by favorable electrostatic interactions
between the positively charged ammonium group of the analogue and the negatively charged PPi
anion. Surprisingly, the active site is sufficiently flexible to accommodate analogues with
partially or completely incorrect stereochemistry. Although this permissiveness in binding is
unanticipated, based on the stereochemical precision of catalysis that leads exclusively to the (+)aristolochene stereoisomer, it suggests the ability of the active site to enable controlled
reorientation of intermediates during the cyclization cascade. Taken together, these structures
illuminate important aspects of the catalytic mechanism.
Crystal structures of ATAS complexes revealed trapped active site water molecules that
could potentially interact with catalytic intermediates: water "w" hydrogen bonds with S303 and
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N299, water molecules "w1" and "w2" hydrogen bond with Q151, and a fourth water molecule is
coordinated to the Mg2+C ion. There is no obvious role for water in the ATAS mechanism, since
the enzyme exclusively generates a hydrocarbon product. Thus, these water molecules are tightly
controlled so that they cannot react with carbocation intermediates. Steady-state kinetics and
product distribution analyses of eight ATAS mutants designed to perturb interactions with active
site water molecules (S303A, S303H, S303D, N299A, N299L, N299A/S303A, Q151H, and
Q151E) indicate relatively modest effects on catalysis but significant effects on sesquiterpene
product distributions. X-ray crystal structures of S303A, N299A, N299A/S303A, and Q151H
mutants reveal minimal perturbation of active site solvent structure. Seven of the eight mutants
generate farnesol and nerolidol, possibly resulting from addition of the Mg2+C-bound water
molecule to the initially formed farnesyl cation, but no products are generated that would suggest
enhanced reactivity of other active site water molecules. However, intermediate germacrene A
tends to accumulate in these mutants. Thus, apart from the possible reactivity of Mg2+C-bound
water, active site water molecules in ATAS are not directly involved in the chemistry of catalysis,
but instead contribute to the template that governs the conformation of the flexible substrate and
carbocation intermediates.
Finally, fusicoccin A is a diterpene glucoside phytotoxin generated by the fungal
pathogen Phomopsis amygdali that causes the plant disease constriction canker, first discovered
in New Jersey peach orchards in the 1930's. Fusicoccin A is also an emerging new lead in cancer
chemotherapy. The hydrocarbon precursor of fusicoccin A is the tricyclic diterpene
fusicoccadiene, which is generated by a bifunctional terpenoid synthase. Here, we report X-ray
crystal structures of the individual catalytic domains of fusicoccadiene synthase: the C-terminal
domain is a chain elongation enzyme that generates geranylgeranyl diphosphate, and the Nterminal domain catalyzes the cyclization of geranylgeranyl diphosphate to form fusicoccadiene.
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Crystal structures of each domain complexed with bisphosphonate substrate analogues suggest
that three metal ions and three positively charged amino acid side chains trigger substrate
ionization in each active site. While in vitro incubations reveal that the cyclase domain can utilize
farnesyl diphosphate and geranyl diphosphate as surrogate substrates, these shorter isoprenoid
diphosphates are mainly converted into acyclic alcohol or hydrocarbon products. Gel filtration
chromatography and analytical ultracentrifugation experiments indicate that full-length
fusicoccadiene synthase adopts hexameric quaternary structure, and small-angle X-ray scattering
data yield a well-defined molecular envelope illustrating a plausible model for hexamer assembly.
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CHAPTER 2: Mechanistic Insights from the Binding of Substrate and Carbocation
Intermediate Analogues to Aristolochene Synthase

The content of this chapter was originally published in Biochemistry. It is adapted here with
permission from the publisher: Reprinted with permission from M. Chen, N. Al-lami, M. Janvier,
E. L. D’Antonio, J. A. Faraldos, D. E. Cane, R. K. Allemann, and D. W. Christianson.
Mechanistic insights from the binding of substrate and carbocation intermediate analogues to
aristolochene synthase. Biochemistry, 2013, 52, 5441-5453. Copyright 2013 American Chemical
Society.
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Introduction
Aspergillus terreus aristolochene synthase (ATAS) catalyzes the cyclization of farnesyl
diphosphate (FPP) to form the bicyclic eremophilane (+)-aristolochene, which is the hydrocarbon
parent of several fungal toxins such as gigantenone, bipolaroxin, and PR-toxin (Jelen, 2012;
Proctor and Hohn, 1993). Unlike its counterpart in Penicillium roqueforti that produces a mixture
of products, ATAS is a high-fidelity enzyme that generates (+)-aristolochene exclusively
(Felicetti and Cane, 2004). To date, no crystal structures of Penicillium roqueforti aristolochene
synthase or ATAS complexed with analogues of substrate or carbocation intermediates have been
reported in which the active site is locked in the fully closed, active conformation by three Mg2+
ions. Here, we report the structure of the ATAS-Mg2+3 complex with the unreactive substrate
analogue farnesyl thiolodiphosphate (FSPP), as well as the first structures of ATAS-Mg2+3
complexes with ammonium and iminium aza-analogues of possible carbocation intermediates in
the cyclization cascade (Figure 2.1). While carbocation intermediates are of course too short-lived
to be studied in their enzyme complexes by typical X-ray crystallographic methods, the use of
cationic aza-analogues enables the study of molecular strategies for stabilizing and manipulating
the transient carbocation intermediates that they mimic (Aaron et al., 2010; Koksal et al., 2011;
Whittington et al., 2002). Additionally, the binding of aza-analogues with unusual
stereochemistries provides insight on the structural basis of fidelity in the cyclization cascade that
exclusively yields (+)-aristolochene.
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Figure 2.1. Proposed mechanism of (+)-aristolochene generation as catalyzed by A. terreus
aristolochene synthase (PPO = diphosphate; PPO– = inorganic pyrophosphate; PPOH =
protonated inorganic pyrophosphate). Analogues of substrate and possible carbocation
intermediates in the cyclization cascade are shown in green.
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Materials and Methods
Aza-analogues of carbocation intermediates. The syntheses of (4aS,7S)-4a-methyl-7(prop-1-en-2-yl)-2,3,4,4a,5,6,7,8-octahydroquinolin-1-ium (1) and (4aS,7S)-1,4a-dimethyl-7(prop-1-en-2-yl)decahydroquinolin-1-ium (2) have been previously reported (Faraldos et al.,
2010; Faraldos and Allemann, 2011). The syntheses of (3R,6R,9aR)-6,9a-dimethyl-3-(prop-1-en2-yl)decahydroquinolizin-5-ium (3) and (1S,8S,9aR)-1,9a-dimethyl-8-(prop-1-en-2yl)decahydroquinolizin-5-ium (4) were accomplished in 6 and 8 steps, respectively, starting from
the known keto ester (S)-methyl-6-oxo-3-(prop-1-en-2-yl)heptanoate, which was obtained by
degradation of (–)-limonene (Ishmuratov et al., 2012; Kido et al., 1995; Takikawa et al., 1997).
The synthesis of 3 features a modified Curtius rearrangement that gives rise to the 3,6-dialkylated
cyclic imine (R)-6-methyl-3-(prop-1-en-2-yl)-2,3,4,5-tetrahydropyridine after acid-promoted
cyclization (Alsina et al., 1996; Kedrowski, 2003). The latter was easily converted to the final
(3R,6R,9aR)-trialkyl substituted quinolizidine 3 essentially as described by De Kimpe (Tehrani et
al., 2003). This protocol generates an equal amount of the (3R,6S,9aS)-diastereomer of 3. Starting
from the same (S)-configured keto ester, imine 4 was prepared via a Beckmann rearrangement
that provided after cyclization the enantiopure lactam (S)-4-(prop-1-en-2-yl)piperidin-2-one
(Jackman et al., 1982; Mehta et al., 2004). This lactam was then converted to the final
quinolizidine 4 via a tandem aza-Robinson annulation/Michael alkylation/Wolff-Kishner
reduction that installed the syn vicinal methyl groups of 4 with excellent stereospecificity
(Fernandez and Sollhuber, 1987; Guarna et al., 2000; Lacroix et al., 2006). An identical synthetic
protocol was repeated from (+)-limonene to give (1R,8R,9aS)-1,9a-dimethyl-8-(prop-1-en-2yl)decahydroquinolizin-5-ium (5), the enantiomer of quinolizidine 4. The absolute configuration
of amines 3, 4, and 5 was determined using a combination of 1D and 2D NMR experiments and
confirmed by X-ray crystal structure determinations of the perchlorate salts of 3, 4 and 5. Full
details of the syntheses of amines 3-5 will be published separately.
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Preparation of recombinant ATAS. To minimize molecular disorder and simplify
enzyme purification, a new truncation variant of ATAS was prepared in which the first 12
residues at the N-terminus were deleted and replaced by a hexahistidine tag using PCR
mutagenesis. This was achieved in two separate steps. First, to prepare the deletion variant, the
forward and reverse primers for the deletion were as follows: 5'–GTT TAA CTT TAA GAA
GGA GAT ATA CAT ATG CTT GAG CCA CCC CCC TCT ACG TTC–3', and 5'–GAA CGT
AGA GGG GGG TGG CTC AAG CAT ATG TAT ATC TCC TTC TTA AAG TTA AAC–3'.
Plasmids were transformed into Escherichia coli XL1-Blue cells (Novagen) and amplified. They
were purified using miniprep kits and the deletion was confirmed by DNA sequencing. In the
second step, the His6 tag was spliced between M1 and L14 of the deletion variant to generate the
new truncation variant designated His6-Δ12-ATAS. The corresponding primers were: 5'–GTT
TAA CTT TAA GAA GGA GAT ATA CAT ATG CAT CAT CAC CAT CAC CAT CTT GAG
CCA CCC CCC TCT ACG TTC–3', and 5'–CAA ATT GAA ATT CTT CCT CTA TAT GTA
TAC GTA GTA GTG GTA GTG GTA GAA CTC GGT GGG GGG AGA TGC AAG–3'.
Plasmids of His6-Δ12-ATAS were prepared and purified as described above.
Escherichia coli BL21(DE3)-pLysS cells (Stratagene, Agilent) carrying the cDNA for His6Δ12-ATAS (henceforth designated simply “ATAS”) were inoculated in 6×5 mL Luria-Bertani
(LB) medium containing 100 µg/mL ampicillin and grown for 6 hrs at 37 °C with shaking (250
rpm). Each 5 mL culture was used to inoculate 6×1L LB medium containing 100 µg/mL
ampicillin. When OD600 reached 1.0, the temperature was adjusted to 22 °C, and 1 mM isopropyl
β-D-1-thiogalactopyranoside was added to induce protein synthesis. The expression lasted for 7.5
hrs before the cells were pelleted and stored at -80 °C for further use.
The cell pellet was thawed and suspended in 50 mL of Talon (QIAGEN) wash buffer [50
mM 3-(N-morpholino)-propanesulfonic acid (MOPS) (pH 7.0), 300 mM NaCl, 2 mM β24

mercaptoethanol (BME), 10% glycerol]. After sonication, the cell lysate was centrifuged at
15,000 rpm and the supernatant loaded onto a pre-equilibrated Talon column at a flow rate of 2
mL/min. Enzyme was eluted with a 0-150 mM imidazole gradient in Talon wash buffer. The
most active fractions were combined and dialyzed against HiTrap Q HP wash buffer [20 mM 2morpholinoethanesulfonic acid (MES) (pH 6.5), 5mM ethylenediaminetetraacetic acid (EDTA), 5
mM BME, 10% glycerol] (GE Healthcare Life Sciences). After loading on a HiTrap Q HP
column (15 mL), enzyme was eluted with a 0-500 mM sodium chloride gradient in HiTrap Q HP
wash buffer. Selected fractions were pooled, concentrated, and further purified in 25 mM MES
(pH 6.5), 2 mM MgCl2, 150 mM NaCl, 4 mM BME using a HiLoad 26/60 Superdex column (GE
Healthcare Life Sciences). The final ATAS sample was 98% pure as indicated by SDS-PAGE
and was concentrated to 10 mg/mL.
Crystal structure determinations. Crystals of ATAS-inhibitor complexes were prepared
by cocrystallization in hanging drops through the vapor diffusion method at 4 °C. Briefly, a 3 µL
drop of protein solution [10 mg/mL ATAS, 20 mM MES (pH 6.5), 1.9 mM MgCl2, 120 mM
NaCl, 3 mM BME, 1.6 mM sodium pyrophosphate, 1.5 mM inhibitor] was added to a 3 µL drop
of precipitant solution and equilibrated against a 500 µL reservoir of precipitant solution.
Different precipitant solutions were used for the crystallization of different ATAS-inhibitor
complexes as follows: for FSPP (Echelon Biosciences), the precipitant solution was 200 mM
magnesium acetate, 17% polyethylene glycol (PEG) 3350; for 1, the precipitant solution was 100
mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES) (pH 7.7), 200 mM MgCl2,
23% (w/v) PEG 3350; for 2, the precipitant solution was 100 mM Bis-Tris (pH 7.0), 200 mM
Li2SO4, and 27% (w/v) PEG 3350; for 3, the precipitant solution was 100 mM magnesium
formate, 12% PEG 3350; for 4, the precipitant solution was 2% Tacsimate (pH 6.0), 100 mM BisTris (pH 7.0), 16% (w/v) PEG 3350; for 5, the precipitant solution was 200 mM sodium malonate
25

(pH 7.0), 15% (w/v) PEG 3350. Crystals generally appeared within 1 week and grew to
maximum size within 3-4 weeks. Crystals were gradually transferred to cryoprotectant solution
(20 % (v/v) glycerol in mother liquor) and flash-cooled in liquid nitrogen.
X-ray diffraction data were collected at beamlines X25 and X29A of the National
Synchrotron Light Source at Brookhaven National Laboratory, and were indexed, integrated, and
scaled using HKL2000 (Otwinowski and Minor, 1997). Criteria for determining the resolution
cut-off for each data set included Rmerge < 0.140 and I/σ > 1.5 for outer shell data. For the ATAS2 complex at 2.4 Å resolution, we had collected slightly higher resolution data sets in different
experiments, but we were not able to index these data sets. In the data set that we were able to
index, we were limited to 2.4 Å resolution data due to the geometry of the X-ray diffraction
experiment. The Rpim value was calculated using phenix.merging_statistics in the PHENIX GUI
(Karplus and Diederichs, 2012). Molecular replacement was performed with Phaser for
Molecular Replacement in the CCP4i package (McCoy et al., 2007), using a monomer of the
previous determined structure of ATAS as a search probe for rotation function and translation
function calculations (Shishova et al., 2007). All crystals formed in a new space group compared
with that of the previously reported crystals of full-length ATAS and belonged to space group
P3121 with four monomers in the asymmetric unit as a dimer of dimers (Shishova et al., 2007;
Shishova et al., 2008). The quaternary structure of this dimer of dimers is similar but not identical
to that reported for full-length ATAS crystallized in space group P21: one dimer is rotated relative
to the second dimer by approximately 30˚. Refinement and manual model adjustment were
performed with PHENIX and COOT, respectively (Adams et al., 2010; Emsley and Cowtan,
2004). The disordered N-terminus M1-H7 and C-terminus V312-D314 were excluded in most
final models. Refinement statistics are recorded in Table 2.1. MolProbity was used to validate all
structures (Chen et al., 2010).
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Results
ATAS-FSPP complex. The ATAS-FSPP complex crystallizes with four monomers
(designated A-D) in the asymmetric unit as a dimer of dimers, and this arrangement is observed
for all complexes prepared with the new ATAS construct utilized in the current study. Roughly
similar quaternary structure is observed in previously-determined crystal structures of full-length
ATAS in a different space group (Shishova et al., 2007). Significant conformational changes are
triggered by the binding of FSPP and three Mg2+ ions in the active site, and the root-mean-square
(r.m.s.) deviation is 1.2 Å for 241 Cα atoms between the ATAS-FSPP complex and unliganded
ATAS (Figure 2.2) (Shishova et al., 2007). These structural changes include the ordering of the
C-terminal end of helix H and the H-α-1 loop (this helps to "cap" the active site), a short coilhelix transition within the F-G1 loop, and the introduction of a small kink in helix I. These
structural changes are essentially identical to those observed in the ATAS-Mg2+3-PPi complex and
appear to be driven by protein and substrate coordination interactions with the trinuclear
magnesium cluster (Shishova et al., 2007).
A simulated annealing omit map of the ATAS-FSPP complex is shown in Figure 2.3a.
The α-helices surrounding the active site shift ca.1.5 Å inward to facilitate van der Waals
interactions with the isoprenoid chains of FSPP, and the S225-I234 segment, which was
disordered in the unliganded enzyme, becomes ordered and caps the top of the active site. The
side chains of E221, N213, and D84 undergo conformational changes to enable Mg2+
coordination, and the side chains of R169, N213, K220, R308, and Y309 move to donate
hydrogen bonds to the diphosphate group of FSPP. Comparison with the structure of the ATASMg2+3-PPi complex shows that the geometry of metal coordination and hydrogen bond
interactions with the diphosphate group is maintained regardless of whether or not the
diphosphate group is covalently bonded to an isoprenoid (Figure 2.3b) (Shishova et al., 2007).
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Deeper in the hydrophobic cavity, it appears that the side chains of V57, L77, and L80 flip to
better encase the isoprenoid chain of FSPP (admittedly, these conformational changes could also
be the result of refinement with higher resolution diffraction data). The structure of the ATASFSPP complex is essentially identical in monomers A-C; slight differences are observed in
monomer D, presumably due to the somewhat noisy electron density that characterizes FSPP.
The intermolecular interactions of the diphosphate group of FSPP appear to indirectly
influence the isoprenoid chain conformation. The previously determined structure of ATAS
complexed with 2-fluorofarnesyl diphosphate revealed the binding of only one Mg2+ ion to an
incomplete closed active site (Shishova et al., 2008). Consequently, the isoprenoid conformation
and orientation of 2-fluorofarnesyl diphosphate is “flipped” relative to that now observed for
FSPP. Therefore, we conclude that a full complement of 3 Mg2+ ions is required to achieve
complete active site closure, which in turn is required to achieve a catalytically-productive
substrate conformation (Aaron and Christianson, 2010).
In the ATAS-FSPP complex, the distance between C10 and C1 of FSPP is 4.6 Å (monomer
A); additionally, the orientation of the C1-S bond with respect to the π system at C10 would not
support the C1-C10 bond forming reaction that initiates the cyclization cascade. Since the
isoprenoid chain of FSPP is otherwise bound with a productive conformation, however, with the
C14 and C15 methyl groups and the terminal isopropylidene group adopting a conformation that
would lead to the formation of (S)-(–)-germacrene A as outlined in Figure 2.1, all that would be
necessary for a fully productive conformation would be a ~90˚ rotation about the C3-C2-C1-S
dihedral angle to align the C1-S bond for backside attack by the π system at C10, which would
give rise to the observed inversion of configuration at C1 (Cane et al., 1989).
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Studies with isotopically labeled FPP have demonstrated that the initial cyclization
reaction forming (S)-(–)-germacrene A requires regiospecific deprotonation of the C13 cis-methyl
group of the germacryl cation as shown in Figure 2.1 (Cane et al., 1990). Although the phenolic
side chain of Y61 is 3.7 Å away from the C13 cis-methyl group of FSPP (monomer A),
mutagenesis studies of this residue show that while it is required for optimal catalytic activity,41 it
is not obligatory for the generation of (+)-aristolochene (Felicetti and Cane, 2004). Thus, Y61
cannot be a catalytically required general base. The C13 cis-methyl group is only 4.0 Å from the
thiophosphate sulfur atom of FSPP, however, suggesting the possibility that the corresponding
oxygen atom of the diphosphate group of FPP could serve as the general base responsible for the
regiospecific proton elimination from the intermediate germacryl cation intermediate shown in
Figure 2.1.
It is interesting to note that a water molecule, labeled "w" in Figure 3, is trapped in the
upper active site. This water molecule is fixed in place by hydrogen bonds with N213, N299, and
S303. The C13 cis-methyl group of FSPP is 3.9 Å away from water molecule "w" while the C12
trans-methyl group of FSPP is 3.0 Å away (monomer A). Based on the observed binding
conformation of FSPP, water molecule "w" is unlikely to mediate the regiospecific deprotonation
of the C13 cis-methyl group.
Finally, the steric bulk of aromatic amino acids often defines in large part the active site
contour of a terpenoid cyclase, and this is the case for ATAS. Active site aromatic residues thus
play an important role in chaperoning the binding conformation of the flexible isoprenoid
substrate. The C1-C4 isoprenoid unit of FSPP makes van der Waals contacts with the side chain
of F147, while the distal C9-C12 isoprenoid unit is nestled within a shallow crevice formed by
the side chains of Y61, F81, and W302. Aromatic residues may also provide electrostatic
stabilization of carbocation intermediates and their flanking transition states through cation-π
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interactions (Dougherty, 1996; Dougherty, 2012; Faraldos et al., 2011).
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Figure 2.2. Structural comparison of unliganded ATAS (left) with the ATAS-FSPP complex
(right) illustrating conformational changes triggered by the binding of FSPP and 3 Mg2+ ions in
the active site.

31

Figure 2.3. Zoom-in view of ATAS-FSPP active site. (a) Simulated annealing omit map of FSPP
(contoured at 4.0σ) bound to monomer A in the ATAS- Mg2+3-FSPP complex. Atoms are colorcoded as follows: C = yellow (protein) or gray (FSPP), O = red, N = blue, P = orange, S = yellow,
Mg2+ ions = silver spheres, solvent molecules = red spheres. Metal coordination interactions are
shown as red dotted lines; hydrogen bond interactions are shown as black dotted lines. Water
molecule "w" is trapped in the active site along with FSPP. (b) Superposition of the ATASMg2+3-FSPP complex (color-coded as in (a)) and the ATAS-Mg2+3-PPi complex (all atoms pale
cyan).
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ATAS-1 complex. Even though its lacks an N-methyl substituent, iminium cation 1 mimics
the eudesmane cation intermediate of the ATAS reaction, presuming that the sp2-hybridized
iminium nitrogen is protonated (pKa ≈ 7-8) and positively charged (Figure 2.1) (Faraldos and
Allemann, 2011; Faraldos et al., 2010). The simulated annealing omit map of this complex
(Figure 2.4a) reveals that the Mg2+3 cluster and PPi group bind with full occupancy and make
similar interactions to those observed in the ATAS-FSPP complex, thereby ensuring a fully
closed active site conformation. The structure of the ATAS-1 complex is essentially identical in
monomers A-C; slight differences are observed in monomer D, possibly due to somewhat noisy
electron density. In general, active site residues adopt nearly identical conformations in the
ATAS-1 and ATAS-FSPP complexes. Intriguingly, however, the orientation of 1 is flipped ~180˚
relative to that of FSPP, such that the isopropylidene group is sandwiched between F81 and F147
rather than in the shallow crevice formed by the side chains of Y61, F81, and W302 (Figure
2.4b). Accordingly, the iminium NH group of 1 donates two hydrogen bonds to the PPi group.
Thus, favorable electrostatic and hydrogen bond interactions appear to play a dominant role in
governing the binding orientation of 1.
Trapped water molecule "w" observed in the ATAS-FSPP complex is also present in the
ATAS-1 complex and it makes a similar array of hydrogen bond interactions with N213, N299,
and S303. Presuming that water molecule "w" remains bound upon the binding of the actual
substrate FPP, hydrogen bond interactions presumably restrain water molecule "w" so that it
cannot react with any carbocation intermediates since ATAS does not generate any hydroxylated
products (Felicetti and Cane, 2004). Accordingly, this water molecule appears to be an integral
part of the active site contour and inert with regard to the chemistry of catalysis.
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Figure 2.4. Zoom-in view of ATAS-1 active site. (a) Simulated annealing omit map of iminium
cation 1 (contoured at 4.0σ) bound to monomer A in the ATAS-1 complex. (b) Superposition of
the ATAS-1 complex (color-coded as in (a)) and the ATAS-FSPP complex (all atoms pale cyan).
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ATAS-2 complex. The simulated annealing omit map of this complex (Figure 2.5a)
reveals that the Mg2+3 cluster, the PPi anion, and tertiary amino cation 2 bind with full occupancy,
and the active site adopts a fully closed conformation. Although the resolution of this structure
(2.4 Å) is the lowest of the structures described in the current work, the electron density envelope
outlining 2 is reasonably well-defined in all four monomers and the structure of the ATAS-2
complex is essentially identical in all four monomers.
Tertiary amino cation 2 mimics the eudesmane cation intermediate and binds with an
orientation somewhat similar to that of 1, in that the isopropylidene group lies between F81 and
F147. The positively charged amino group of 2 donates a hydrogen bond to the PPi group,
although it is tilted slightly downward and shifted toward F147 and F81 relative to the position of
1 to avoid a steric clash between the N-methyl substituent and the PPi group. Consequently, the
side chain of L77 is flipped to accommodate the isopropylidene group of 2. The trapped water
molecule “w” is present, but it does not make any close contacts with 2. A superposition of the
ATAS-1 and ATAS-2 complexes is shown in Figure 2.5b.
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Figure 2.5. Zoom-in view of ATAS-2 active site. (a) Simulated annealing omit map of tertiary
ammonium cation 2 (contoured at 2.6σ) bound to monomer A in the ATAS-2 complex. (b)
Superposition of the ATAS-2 complex with the ATAS-1 complex (all atoms pale cyan).
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ATAS-3 complex. The simulated annealing omit map of this complex (Figure 2.6a)
reveals that the Mg2+3 cluster, PPi anion, and 3 bind with full occupancy in a fully closed active
site. The structure of the ATAS-3 complex is essentially identical in all four monomers.
Compound 3 partially mimics the possible carbocation intermediate that would be formed in a
stepwise mechanism in which the eudesmane cation undergoes a 1,2-hydride transfer to form a
tertiary carbocation at the ring-fusion carbon (Figure 2.1). However, 3 is an imperfect mimic,
because the stereochemistry at the C3 atom is R instead of S, the protonated amino nitrogen is
sp3-hybridized rather than sp2-hybridized, and the analogue adopts a conformation comparable to
that of a cis-decalin. Even so, the binding orientation of 3 is somewhat reminiscent of that of
FSPP, in that the isopropylidene group is nestled with the cavity formed by the side chains of
Y61, F81, and W302 (Figure 2.6b). Although the conformations of surrounding residues are
identical to those observed in previous structures, F81 moves slightly toward the bottom of the
cleft to accommodate 3. Notably, there is an additional water molecule, labeled "ww", that
hydrogen bonds with a Mg2+C-bound water molecule, donates a hydrogen bond to the PPi group,
and accepts a hydrogen bond from the protonated amino group of 3.
Despite the fact that 3 is an imperfect analogue of a possible carbocation intermediate in
the ATAS reaction, it is interesting to note that the methylene group corresponding to that which
undergoes stereospecific deprotonation of the H-8si atom is oriented toward the PPi anion. This
suggests the possibility that the PPi anion could serve as a general base that removes the H-8si
proton in the cyclization cascade leading to (+)-aristolochene formation as shown in Figure 2.1
(Cane et al., 1990).
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Figure 2.6. Zoom-in view of ATAS-3 active site. (a) Simulated annealing omit map of tertiary
ammonium cation 3 (contoured at 3.5σ) bound to monomer B in the ATAS-3 complex. Atoms
are color-coded as follows: C = yellow (protein) or gray (3), O = red, N = blue, P = orange, S =
yellow, Mg2+ ions = silver spheres, solvent molecules = red spheres. Metal coordination,
hydrogen bond, and cation-p interactions are shown as red, black, and green dotted lines,
respectively. Water molecules "w" and "ww" are trapped in the active site along with 3. (b)
Superposition of the ATAS-3 complex (color-coded as in (a)) with the ATAS-FSPP complex (all
atoms pale cyan).
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ATAS-4 complex. The simulated annealing omit map of this complex (Figure 2.7a)
reveals that the Mg2+3 cluster, PPi anion, and 4 bind with full occupancy, ensuring a fully closed
active site conformation. The structure of the ATAS-4 complex is essentially identical in
monomers A-C; slight differences are observed in monomer D, presumably due to the relatively
poor electron density that characterizes 4. Tertiary amino cation 4 mimics the final carbocation
intermediate proposed in the stepwise mechanism leading to the formation of (+)-aristolochene.
Although the amino nitrogen bears a positive charge and all stereocenters are correctly
constructed, the sp3-hybridization of the cationic tertiary amino group makes it an imperfect
mimic of the planar sp2-hybridized tertiary carbocation shown in Figure 2.1. The amino nitrogen
of 4 faces the PPi group, and van der Waals interactions occur between the ring carbon atoms of 4
and the PPi group (Figure 2.7a). The isopropylidene group of 4 is nestled in the aromatic cleft
formed by Y61, F81, and W302. This is the same general location occupied by the terminal
isoprenoid unit of FSPP, as shown in the superposition in Figure 2.7b. If this orientation were
adopted by the final carbocation intermediate in catalysis, it is interesting to note that the C8
methylene group is oriented toward the PPi anion. This further supports the possibility that the PPi
anion could serve as a general base for the stereospecific deprotonation of the H-8si atom in the
cyclization of FPP to (+)-aristolochene.
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Figure 2.7. Zoom-in view of ATAS-4 active site. (a) Simulated annealing omit map of tertiary
ammonium cation 4 (contoured at 3.0σ) bound to monomer A in the ATAS-4 complex. (b)
Superposition of the ATAS-4 complex (color-coded as in (a)) with the ATAS-FSPP complex (all
atoms pale cyan).
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ATAS-5 Complex. In order to probe stereochemical discrimination in the active site of
ATAS, we prepared the complex with tertiary ammonium cation 5. This analogue has opposite
stereochemistry at all stereocenters relative to 4, including the stereochemistry at the protonated
tertiary amino group. The stereochemistry of 5 is therefore inconsistent with that of any structure
encountered in the natural ATAS mechanism shown in Figure 1. Despite this fact, 5 is readily
accommodated in the active site of ATAS, which is stabilized in the fully closed conformation by
Mg2+3-PPi bound with full occupancy (Figure 2.8a). The structure of the ATAS-5 complex is
essentially identical in monomers A-D, even though the electron density of 5 in monomer D is
somewhat noisy. To avoid a steric clash with the isopropylidene group, Y61 rotates ~90˚ relative
to its observed conformation in the ATAS-4 complex, but the conformations of other active site
residues are essentially identical to those observed in the ATAS-4 complex. As in other
complexes, trapped water molecule "w" hydrogen bonds with N213, N299, and S303; the
additional trapped water molecule, "ww" is also observed and is stabilized by hydrogen bond
interactions with the PPi group, a Mg2+C-bound water molecule, and the amino group of 5. A
superposition comparing the binding modes of correct stereoisomer 4 and incorrect stereoisomer
5 complexed with ATAS is shown in Figure 2.8b.
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Figure 2.8. Zoom-in view of ATAS-5 active site. (a) Simulated annealing omit map of tertiary
ammonium cation 5 (contoured at 3.1σ) bound to monomer A in the ATAS-5 complex. (b)
Superposition of the ATAS-5 complex with the ATAS-4 complex (all atoms pale cyan).
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Discussion
Aromatic triad Y61, F81, and F147 enables cation-π stabilization and contributes to
the template for FPP cyclization. The structures of the several bicyclic aza analogues of
carbocation intermediates bound in the active site of ATAS demonstrate the feasibility of cation
stabilization through charge-quadrupole or cation-π interactions (Dougherty, 1996; Dougherty,
2012), as originally suggested in the first reported structures of terpenoid cyclases (Lesburg et al.,
1997; Starks et al., 1997; Wendt et al., 1997). While different positions and orientations are
observed for each, analogues 1-4 bind in a region that is encircled by the faces of three aromatic
residues: Y61, F81, and F147 (Figures 2.4-2.7). Due to the conformational change of Y61 that
accommodates the binding of analogue 5, which has "incorrect" stereocenters, the edge of this
residue rather than its face is oriented toward the active site cavity (Figure 2.8). Nevertheless, the
binding of aza analogues 1-4, which better mimic carbocation intermediates in the ATAS
reaction, suggests that Y61, F81, and F147 are ideally positioned to stabilize carbocation
intermediates and their intervening transition states in the ATAS reaction.
Residues Y61, F81, and F147 are conserved in the closely related aristolochene synthase
from P. roqueforti (PRAS) as Y92, F112, and F178, consistent with a conserved functional role
for these aromatic residues. Interestingly, Y92F PRAS exhibits lower catalytic activity but
nevertheless retains the ability to generate aristolochene (Felicetti and Cane, 2004; Calvert et al.,
2002); the Y92V, Y92C, and Y92A mutations similarly exhibit compromised catalytic activity
but also generate (Ε)-β-farnesene, demonstrating that the bulky tyrosine side chain is part of the
template that enforces the cyclization of FPP to form aristolochene (Calvert et al., 2002;
Deligeorgopoulou and Allemann, 2003). A template function for the aromatic triad is consistent
with the structure of the ATAS-FSPP complex (Figure 2.3), in which Y61, F81, and F147 make
significant van der Waals contacts with the flexible isoprenoid group of the substrate analogue,
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thereby enforcing its bound conformation.
Structural studies of the unrelated bacterial sesquiterpene cyclase epi-isozizaene synthase
have also shown that three aromatic residues (F95, F96, and F198) encircle the active site and
make cation-π interactions with the benzyltriethylammonium cation (Aaron et al., 2010); the
bacterial sesquiterpene cyclase pentalenene synthase also contains three aromatic residues (F76,
F77, and Y146) oriented so as to enable cation-π interactions in the active site (Lesburg et al.,
1997). Alternatively, sesquiterpene cyclase active sites can be defined by the faces of only two
aromatic residues capable of engaging in cation-π interactions, such as those of 5-epiaristolochene synthase (W273 and Y527) (Starks et al., 1997), trichodiene synthase (Y93 and
F157) (Rynkiewicz et al., 2001), and δ-cadinene synthase (W279 and Y527) (Gennadios et al.,
2009). Thus, a working hypothesis is that a sesquiterpene cyclase active site can be encircled by a
triad of aromatic residues with general primary structure (F,Y)X1-20FX70-100(F,Y); if not, then it
contains two aromatic residues quite distant from one another in the protein primary structure
with their ring faces oriented toward the active site.
Charge-charge interactions with the PPi anion appear to govern the orientation of
cationic aza-analogues. It is notable that bicyclic aza analogues 1-4 bind with two general
orientations. In one orientation, the branched isopropylidene group is nestled between F81 and
F147 (analogues 1 and 2); in the other orientation, the isopropylidene group is oriented toward
Y61 (analogues 3 and 4). In the ATAS-FSPP complex, the isopropylidene C12 and C13 atoms
are similarly oriented toward Y61 (Figure 2.1). Although it is unlikely that the carbocation
intermediates in the ATAS reaction exhibit exceptional mobility during catalysis that would
facilitate lengthwise flipping of the bicyclic ring system, the ability of ATAS to accommodate
multiple conformations of the aza analogues suggests the intriguing possibility that the transiently
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generated, uncharged germacrene A intermediate may undergo a reorientation within the active
site cavity so as to present the 6,7-double bond to the co-generated pyrophosphoric acid, allowing
protonation at C6, followed by transannular cyclization, rearrangement, and final deprotonation
of H-8si by the appositely located PPi anion. In principle, the requisite reorientation of the
germacrene could take place either by a ~120° rotation about an axis passing through the average
plane of the germacrene A ring, or by a ~180° rotation about an axis passing through C5 and C10.
Since the PPi ion appears to be firmly anchored by the surrounding network of ion-metal,
oxyanion-cation, and hydrogen bond interactions, reorientation of the germacrene A intermediate
would allow the pyrophosphate to access both C6 and C8 in order to mediate the key protonation
and eventual deprotonation steps at these centers with the observed stereochemistry.
Interestingly, in each enzyme-inhibitor complex, the cationic ammonium or iminium
group is oriented toward the PPi anion, so the binding orientation of each aza analogue appears to
be governed largely by favorable charge-charge interactions with the PPi anion and not just
cation-π interactions with aromatic residues. Positively-charged ammonium groups of aza
analogues 1 and 2 donate hydrogen bonds directly to the PPi anion, and aza analogues 3 (and 5)
donate hydrogen bonds to water molecule "ww", which in turn donates a hydrogen bond to the
PPi anion. Aza analogue 4, while not hydrogen bonding to the PPi anion, is oriented so that the
positively-charged amino group is near the PPi anion. Presumably, the thermodynamically
favored binding position and orientation of the aza analogue in the enzyme active site is attained
as enzyme and inhibitor equilibrate in the cocrystallization experiment. Thus, the observation of
two general binding orientations for these analogues is likely to be an artifact of favorable chargecharge interactions between the aza analogues and the PPi anion.
Which orientation, then, corresponds to the productive orientation of catalysis? We
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hypothesize that the catalytically productive orientation is that which orients the isopropylidene
group toward Y61, since this orientation better corresponds to that observed for the binding of the
substrate analogue FSPP. The binding orientation and conformation of FSPP is not subject to
direction by PPi anion-cation interactions, and FSPP is bound with a nearly-productive
conformation. Notably, this is the first crystal structure of a terpenoid cyclase in which a bound
substrate analogue adopts a conformation similar to that required for the precatalytic enzymesubstrate complex. The crystal structures of the ATAS-3 and ATAS-4 complexes also provide
substantial mechanistic and conformational information. Having previously advanced the idea
that aza analogues that are more product-like in structure are more likely to be bound with
catalytically-productive orientations based on several crystal structures of terpenoid cyclase-aza
analogue complexes (Vedula et al., 2005; Whittington et al., 2002), we suggest that since 4 is the
most product-like of all the aza analogues studied, the corresponding ATAS-4 complex represents
the most catalytically-productive orientation of the bicyclic aza analogue in the ATAS active site.
This is consistent with the orientation of the final carbocation intermediate of a terpenoid
cyclization being proximal to the PPi anion, which may play a key role in quenching the final
carbocation intermediate (vide infra).
Role of active site water in catalysis. The active site of a terpenoid cyclase is generally
quite hydrophobic, more complementary in chemical nature to a nonpolar isoprenoid hydrocarbon
than to a polar molecule such as water. However, it is intriguing that substrate binding to ATAS
does not displace all of the water molecules presumed to solvate the active site in the unliganded
enzyme. Trapped water molecule "w" is held firmly in place by hydrogen bonds with N213,
N299, and S303 in all structures (Figures 2.3-2.8). Since ATAS is a high-fidelity cyclase and
there is no evidence for hydroxylated products, this water molecule cannot be acting as a
nucleophile. Moreover, a role for this water molecule as a general base is ruled out based on its
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intermolecular contacts in the ATAS-FSPP complex. Therefore, trapped water molecule "w"
simply comprises part of the active site contour, comparable to the trapped water molecule
observed in ligand complexes with bornyl diphosphate synthase (Whittington et al., 2002).
Also interesting is water molecule "ww", which is observed in the ATAS-3 and ATAS-5
complexes; however, both 3 and 5 possess incorrect stereochemistry with regard to the ATAS
reaction, so we cannot make conclusive mechanistic statements about this water molecule. Since
water molecule "ww" is not observed in the ATAS-FSPP complex, the initial assumption would
be that it could not enter the active site during catalysis – ostensibly, it only binds when the
enzyme is allowed to equilibrate with an aza analogue during the cocrystallization experiment.
However, water molecule "ww" is hydrogen bonded to the PPi anion as well as a Mg2+C-bound
water molecule, which in turn is exposed to bulk solvent. If sufficient void volume were created
upon formation of the germacrene A intermediate to open up a new water binding site, this would
allow a Mg2+C-bound water molecule to move into the "ww" position and another water molecule
from bulk solvent to move into the vacant coordination site on Mg2+C. If water molecule "ww" is
present during catalysis, it is highly controlled, in that it cannot react with any carbocation
intermediates.
Role of the PPi anion in catalysis. As previously discussed, the PPi anion appears poised
to accept a proton from the cis-C13 methyl group of FPP based on the structure of the ATASFSPP complex, consistent with the regiochemistry previously established for this step of the
reaction (Cane et al., 1990). Since the PPi anion is a weak base, especially as coordinated to three
Mg2+ ions, the protonated PPi anion could serve as the Brønsted acid that protonates the C=C
bond at C6 of the reoriented germacrene A intermediate (Figure 2.1). Although the proton
initially abstracted from C13 of FPP is not added back to the substrate (Cane et al., 1990; Miller
et al., 2008). this does not rule out the possible role of the protonated PPi anion as a general acid,
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provided that exchange of the proton with water is faster than reprotonation of the newly
generated germacrene A.
The PPi anion hydrogen bonds to the same Mg2+C-bound water molecule in the ATAS-2,
ATAS-4, and ATAS-5 complexes, as well as the ATAS-PPi complex (Shishova et al., 2007); this
Mg2+C-bound water molecule is exposed to bulk solvent. Thus, if the PPi anion regiospecifically
deprotonates the germacryl cation intermediate from the carbon derived from the cis-C13 methyl
group of FPP, and if proton transfer between the conjugate acid of the PPi anion, the Mg2+Cbound water molecule, and bulk solvent is rapid relative to the rate of C=C bond protonation,
then the proton (or deuteron) derived from the cis-C13 methyl group of FPP would exchange with
solvent before reprotonation of the germacrene A intermediate. This likely accounts for the fact
that the proton initially abstracted from C13 of FPP is not added back to the substrate (Cane et al.,
1990; Miller et al., 2008).
In the final step of catalysis, the H-8si proton of the C8 methylene group is oriented
toward the PPi anion, suggesting that the PPi anion also serves as the general base for the
stereospecific deprotonation resulting in formation of (+)-aristolochene. Water molecule "ww" is
also located on the same side of analogue 3 as the PPi anion, so it is possible that water molecule
"ww" could function in this role as well. Since water molecule "ww" is not observed in the
ATAS-4 complex, which mimics the putative bound final carbocation intermediate, this may
disfavor the role of water molecule "ww" as a proton acceptor. Regardless of whether it is the PPi
anion or water molecule "ww" that accepts the proton from the final carbocation intermediate,
this proton is presumably released rapidly into bulk solvent through exchange with the hydrogen
bonded Mg2+C-bound water molecule.
An emerging role for the PPi anion as a general base-general acid-general base in the
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ATAS mechanism is suggested by the ATAS crystal structures and is consistent with available
enzymological measurements. The potential for product-assisted catalysis by the PPi anion was
first suggested by Caruthers and colleagues in the analysis of structure-function relationships in
aristolochene synthase from Penicillium roqueforti (Caruthers et al., 2000). Subsequently, the
structure of FPP synthase from Escherichia coli complexed with dimethylallyl-Sthiolodiphosphate (DMASPP) and isopentenyl diphosphate similarly implicated the diphosphate
group of DMASPP as the stereospecific general base in the chain elongation reaction (Poulter and
Rilling, 1978; Hosfield et al., 2004). Recent studies suggest that active site arginine residues that
hydrogen bond with the diphosphate group of FPP play an important role in activating the
diphosphate leaving group and modulating the chemistry of the diphosphate/PPi anion in its
potential function as a general acid (Faraldos et al., 2012).
Stereochemical discrimination in the ATAS active site. It is surprising that ATAS is
capable of binding carbocation analogue 5, which mimics the incorrect stereoisomer of the
product (+)-aristolochene, particularly in view of the fact that ATAS is a high-fidelity cyclase –
not only does ATAS generate no other cyclic sesquiterpene with an alternative carbon skeleton,
but it generates no stereochemical product other than (+)-aristolochene. Such strict product
specificity implies that ATAS has evolved to catalytic perfection – in this case, "perfection" does
not refer to catalytic efficiency, but instead to the fidelity of the FPP cyclization cascade. A
catalytically-perfect cyclase has evolved with an active site contour that serves as a template for
the generation of one sole product. While the active site contour of ATAS is quite product-like,
i.e., it is complementary in shape to that of (+)-aristolochene, it is remarkable that modest
flexibility in the active site accommodates an aristolochene analogue with incorrect
stereochemistry.
Transition state binding in an enzyme active site is under kinetic control, with the
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reaction coordinate from one intermediate to the next being governed by the barrier height
separating the intermediates and not the relative binding energies of the intermediates. Thus, the
orientation, conformation, and stereochemistry of an analogue designed to mimic a carbocation
intermediate allowed to achieve the most favorable binding energy and structure will not
necessarily reflect the kinetically-favored structure encountered in catalysis for the corresponding
intermediate or transition state. However, the orientations and conformations of stereochemicallycorrect analogues may become thermodynamically more favorable as the product structure is
approached (Vedula et al., 2005), and this appears to be the case in the ATAS-4 complex. Thus, a
terpenoid cyclase active site – even that of a high-fidelity terpenoid cyclase – may be capable of
binding terpenoids and terpenoid analogues with "incorrect" structures and stereochemistries,
even though these structures and stereochemistries are not ordinarily encountered under kinetic
control during the cyclization cascade. Our future studies will continue to probe these aspects of
structural and stereochemical discrimination in terpenoid cyclization reactions catalyzed by
ATAS.
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Table 2.1. Data collection and refinement statistics of ATAS with substrate and intermediate
analogues

Complex

ATAS-FSPP

ATAS-1

ATAS-2

Resolution limits (Å)
Total/unique
reflections measured
Space group
Unit cell: a, c (Å)
Rmergea,b
I/σ(I)a
Redundancya
Completeness (%)a
B. Refinement

50.0-1.90
1605556/142524

50.0-2.15
537459/96119

50.0-2.40
783788/69718

P3121
124.0, 203.5
0.102 (*)
30.4 (1.5)
11.3 (10.9)
100.0 (100.0)

P3121
123.4, 201.6
0.106 (0.569)
16.3 (3.2)
5.6 (5.6)
99.1 (99.9)

P3121
122.8, 202.5
0.094 (0.277)
30.0 (9.3)
11.2 (9.4)
100 (100)

Reflections used in
Refinement/test set
Rworkc
Rfreec
Protein atomsd
Ligand atomsd
Mg2+ ionsd
Solvent atomsd
Glycerol atomsd
Avg. B factors (Å2)
main chain
side chain
ligand
Mg2+ ions
solvent
R.m.s. deviations

142431/7147

96109/4811

69619/3517

0.189
0.226
9831
96
12
978
12

0.208
0.240
9816
92
12
892
0

0.174
0.212
9816
96
13
980
24

32
37
33
27
37

19
22
13
16
27

26
28
35
23
30

bonds (Å)
angles (deg)
Ramachandran Plot
(%)
Allowed
Additionally allowed
Generously allowed
disallowed
PDB accession code

0.014
1.4

0.005
0.8

0.005
0.8

95.1
4.9
0.0
0.0
4KUX

95.3
4.7
0.0
0.0
4KVI

94.8
5.2
0.0
0.0
4KVD

A. Data Collection

(Continued on P53)
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Complex

ATAS-3

ATAS-4

ATAS-5

Resolution limits (Å)
Total/unique
reflections measured
Space group
Unit cell: a, c (Å)
Rmergea,b
I/σ(I)a
Redundancya
Completeness (%)a
B. Refinement

50.0-2.10
1104453/105878

50.0-1.95
965747/130854

50.0-1.86
1034908/151303

P3121
124.4, 202.9
0.127 (0.702)
19.3 (3.4)
10.4 (9.9)
100.0 (100.0)

P3121
124.3, 203.0
0.132 (0.681)
14.1 (3.3)
7.4 (7.3)
99.4 (98.8)

P3121
123.8, 202.1
0.102 (0.763)
17.5 (2.8)
6.8 (6.6)
100 (100)

Reflections used in
Refinement/test set
Rworkc
Rfreec
Protein atomsd
Ligand atomsd
Mg2+ ionsd
Solvent atomsd
Glycerol atomsd
Avg. B factors (Å2)
main chain
side chain
ligand
Mg2+ ions
solvent
R.m.s. deviations

105808/5287

130821/6591

150235/7536

0.194
0.229
9839
96
12
980
12

0.191
0.238
9831
96
12
1077
6

0.193
0.226
9831
96
12
1024
12

29
32
31
23
35

26
30
29
22
31

24
28
26
18
29

bonds (Å)
angles (deg)
Ramachandran Plot
(%)
Allowed
Additionally allowed
Generously allowed
disallowed
PDB accession code

0.005
0.8

0.007
1.0

0.016
1.5

95.0
5.0
0.0
0.0
4KVW

95.5
4.5
0.0
0.0
4KVY

95.2
4.8
0.0
0.0
4KWD

A. Data Collection

a

Numbers in parentheses refer to the highest resolution shell of data. bRmerge for replicate reflections, R =
∑|Ih – 〈Ih〉|/∑〈Ih〉; Ih = intensity measure for reflection h; and 〈Ih〉 = average intensity for reflection h
calculated from replicate data. cRwork = ∑||Fo| – |Fc||/∑|Fo| for reflections contained in the working set. Rfree =
∑||Fo| – |Fc||/∑|Fo| for reflections contained in the test set held aside during refinement (5% of total). |Fo|
and |Fc| are the observed and calculated structure factor amplitudes, respectively. dPer asymmetric unit.
*Rmerge value higher than 1.000 are reported as 0.000 by HKL2000. Given the exceptionally high
redundancy of 10.9 for the outer shell of this dataset, Rpim is a more appropriate measure of data quality
than Rmerge. For this dataset, Rpim = 0.037 (0.572).
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CHAPTER 3: Probing the Role of Active Site Water in the Sesquiterpene Cyclization
Reaction Catalyzed by Aristolochene Synthase

The content of this chapter was originally published in Biochemistry. It is adapted here with
permission from the publisher: Reprinted with permission from M. Chen, W. K. W. Chou, N. AlLami, J. A. Faraldos, R. K. Allemann, D. E. Cane, and D. W. Christianson. Probing the role of
active site water in the sesquiterpene cyclization reaction catalyzed by aristolochene synthase.
Biochemistry, 2016, in press. Copyright 2016 American Chemical Society.
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Introduction
The active site of a terpenoid cyclase is typically lined by hydrophobic aliphatic and
aromatic residues, comprising a three-dimensional template that binds the flexible substrate and
chaperones carbocation intermediates through a specific sequence of carbon-carbon bondforming reactions (Lesburg et al., 1997; Starks et al., 1997; Wendt et al., 1997). The volume of a
terpenoid cyclase active site is often just slightly larger than the volume of the isoprenoid
substrate, so as to ensure a snug fit between the template and the flexible isoprenoid substrate
(Koksal et al., 2011; Rynkiewicz et al., 2002). In such circumstances, most if not all active site
water molecules are sterically displaced by substrate binding. This also provides chemical
protection for catalysis, since an errant water molecule trapped in the active site could
conceivably quench a carbocation intermediate (Pronin and Shenvi, 2012). Even so, some
terpenoid cyclases generate alcohol products, indicating that capture of the final carbocation
intermediate by water is an essential catalytic strategy (Cane and Watt, 2003; Kawaide et al.,
2011; Nakano et al., 2011; Wang and Cane, 2008;). Moreover, even in cyclases that do not
generate alcohol products, trapped water molecules are occasionally observed in fully closed
active sites complexed with analogues of the substrate, carbocation intermediates, or product
(Whittington et al., 2002). Thus, a terpenoid cyclase must be able to control a trapped active site
water molecule, when present, so that it reacts at the right time – or not at all – in the cyclization
cascade.
The water management strategy in the active site of Aspergillus terreus aristolochene
synthase (ATAS) is particularly intriguing. ATAS is a high fidelity cyclase that converts farnesyl
diphosphate (FPP) exclusively into the sesquiterpene hydrocarbon (+)-aristolochene (Cane and
Kang, 2000; Felicetti and Cane, 2004). There is no obvious role for water in the ATAS
mechanism: a 1,10-cyclization reaction leads to the formation of (S)-(–)-germacrene A, which
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undergoes reprotonation to enable a 1,6-cyclization reaction that ultimately leads to formation of
the bicyclic product (Figure 3.1a) (Cane et al., 1989). However, recent high resolution crystal
structures of ATAS complexes with the unreactive substrate analogue farnesyl-Sthiolodiphosphate (FSPP) as well as aza analogues of carbocation intermediates reveal trapped
active site water molecules in each complex studied (Figure 3.1b). One conserved water molecule
forms a hydrogen bond with N213 (a Mg2+B ligand in the NSE motif), N299, and S303; this water
molecule is conserved in all crystal structures of ATAS in the closed conformation regardless of
the ligand bound in the active site. On the opposite side of the active site, two conserved water
molecules are additionally trapped and hydrogen bonded with Q151 in the upper side of the
active site, adjacent to the DDXXD motif. Finally, a Mg2+C-bound water molecule is exposed to
the upper active site. Since wild-type ATAS generates exclusively (+)-aristolochene and no
hydroxylated products, all of these water molecules must be chemically inert in catalysis.
Therefore, we hypothesize that these water molecules comprise an essential part of the active site
contour which serves as the template for catalysis.
Here, we probe the role of active site water molecules in ATAS by perturbing their
hydrogen bond partners S303, N299, and Q151 through site-directed mutagenesis, and
characterizing the steady-state kinetics and product profiles of each mutant. Interpretation of
these results in view of X-ray crystal structures of selected mutants reveals how the fidelity of
FPP cyclization is influenced by active site water, even when no hydroxylated products are
generated.
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Figure 3.1. Zoom-in view of ATAS active site water molecules. (a) Cyclization of farnesyl
diphosphate (FPP) as catalyzed by A. terreus aristolochene synthase (ATAS). Also shown are the
unreactive substrate analogue farnesyl-S-thiolodiphosphate (FSPP) and the aza analogue of the
final carbocation intermediate. (b) Stereoview showing the structure of the ATAS-FSPP complex
(chain A). Conserved Mg2+C-bound water molecules, as well as active site water molecules w, w1,
and w2, are represented by their approximate van der Waals radii. Atomic color-codes are as
follows: C = light brown (protein) or gray (FSPP), N = blue, O = red, P = orange, S = yellow;
Mg2+ = green spheres, selected Mg2+-bound water molecules = small red spheres, water
molecules w, w1, and w2 = large pink spheres. Hydrogen bond interactions between these water
molecules and Q151, N213, N299, and S303 are indicated by dashed lines.
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Materials and Methods
Site-specific mutants of ATAS were prepared by PCR mutagenesis using the previouslyreported His6-Δ12-ATAS plasmid with the primers listed in Table 3.1; mutants were expressed
and purified as previously reported with minor modifications. Briefly, LB medium (6 × 1 L)
containing 100 µg/mL ampicillin and 34 µg/mL chloramphenicol was inoculated with a 5-mL
starting culture and grown at 37 °C with aeration. Cells were induced with 0.05-0.3 mM
isopropyl β-D-1-thiogalactopyranoside at 16 °C when the optical density at 600 nm reached 0.81.0. After expression for 18 h, cells were pelleted by centrifugation.
For each mutant, the cell pellet was resuspended in Ni-NTA wash buffer [50 mM
K2HPO4 (pH 7.7), 300 mM NaCl, 10% (v/v) glycerol, and 3 mM tris(2-carboxyethyl)-phosphine
hydrochloride (TCEP)]. Cells were lysed by sonication for 10-20 min. After centrifugation, cell
debris was discarded and supernatant was loaded on a Ni-NTA column. Protein was eluted with a
0–400 mM imidazole gradient in Ni-NTA wash buffer. Occasionally, protein samples were
additionally purified using a 10-mL HiTrap Q HP column (GE Healthcare) after exchange to Q
wash buffer [10 mM Tris (pH 8.0) and 10 mM NaCl] when additional impurities were detected in
some preparations. Elution was performed with a 0–500 mM NaCl gradient in Q wash buffer.
Fractions were analyzed by SDS-PAGE, and the most active ones were combined, concentrated,
and loaded onto a HiLoad 26/60 Superdex column (GE Healthcare) pre-equilibrated with 25 mM
MES (pH 6.5), 150 mM NaCl, 2 mM MgCl2, 10% (v/v) glycerol, and 3 mM TCEP. Final protein
samples were 95-98% pure based on SDS-PAGE analysis.
Product assays were carried out in duplicate on a 5-mL scale using a previously described
method with slight modifications (Li et al., 2014). Reactions were initiated at 30 °C by adding
enzyme into assay buffer containing substrate FPP overlaid with 5 mL n-pentane. After 18-20 h
of reaction, hydrocarbon products were extracted from the reaction mixture with three portions of
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n-pentane; extracts were run through anhydrous MgSO4 to eliminate trace amounts of water.
Samples were then concentrated under vacuum in an ice water bath using a rotary evaporator and
analyzed by gas chromatography-mass spectrometry (GC-MS).
Gas chromatography-mass spectrometry (GC-MS) analyses were performed using an
Agilent 5977A Series GC/MSD instrument (70 eV, electron impact), a 1-µL injection volume,
and a 3 min solvent delay. Achiral GC-MS conditions used a temperature program with a 2 min
hold at 60 °C, a 20 °C min−1 increment to 280 °C, followed by a 2 min hold at 280 °C, and a HP5ms capillary column (0.25 mm ID x 30 m length x 0.25 mm film, Agilent Technologies). Chiral
GC-MS conditions used a temperature program with a 2 min hold at 60 °C, a 3 °C min−1
increment to 220 °C, followed by a 2 min hold at 220 °C, and a CP-Chirasil-Dex CB capillary
column (0.25 mm ID x 25 m length x 0.25 mm film, Agilent Technologies). Comparison of GCMS detected compounds to their standards was done using the MassFinder 4.2.1 program
(http://www.massfinder.com).
To examine how each mutation affected steady-state reaction kinetics, activity assays
were conducted in triplicate on a 100-µL scale using a previously described method with slight
modifications (Li et al., 2014). Purified ATAS mutants were incubated with FPP in 100 µL assay
buffer [25 mM HEPES (pH 8.0) and 5 mM MgCl2] at 30 °C. Concentrations and incubation times
for each mutant were adjusted accordingly in order to measure initial reaction rates. Reactions
were quenched by adding 30 µL 0.5 M ethylenediaminetetraacetic acid (EDTA) and products
were extracted with 1 mL hexane twice. Extracts were passed through a 1-mL silica gel column,
which was washed with 2 mL hexane followed by 1 mL hexane/ethyl ether (11:1). All eluates
were collected in a scintillation vial containing 5 mL scintillation liquid. Radioactive counts were
measured using a Beckman liquid scintillation counter. Control experiments were performed to
determine background counts. Data were processed with Prism software.
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For crystallography, FSPP was purchased from Echelon Biosciences Inc., and
carbocation analogue 4 was synthesized as described in Chapter 2. Crystals of ATAS mutant
complexes with these ligands were prepared by cocrystallization in sitting drops through the
vapor diffusion method at 4 °C. Briefly, a 1-µL drop of protein solution [7-10 mg/mL ATAS
mutant, 20 mM MES (pH 6.5), 1.9 mM MgCl2, 120 mM NaCl, 3 mM TCEP, 1.6 mM sodium
pyrophosphate, 1.5 mM ligand] was added to a 1-µL drop of precipitant solution and equilibrated
against a 60-80 µL reservoir of precipitant solution. Different precipitant solutions were used for
the crystallization of different mutants. For crystallization of the S303A ATAS-4 complex, the
precipitant solution was 200 mM NH4OAc, 20% PEG 3350; for crystallization of the N299A
ATAS-4 complex, the precipitant solution was 200 mM Mg(OAc)2, 20% PEG 3350; for
crystallization of the N299A ATAS-FSPP complex, the precipitant solution was 200 mM
Mg(OAc)2, 20% PEG 3350; for crystallization of the N299A/S303A ATAS-4 complex, the
precipitant solution was 200 mM NaCl, 100 mM HEPES (pH 7.5), 25% PEG 3350; for
crystallization of Q151H ATAS with FSPP, the precipitant solution was 200 mM magnesium
formate, 20% PEG 3350.
After growing to maximum dimensions, crystals of ATAS mutant-ligand complexes were
gradually transferred to a cryoprotectant solution [20-25% (v/v) glycerol in mother liquor] and
flash-cooled in liquid nitrogen. X-ray diffraction data were collected at beamline X29A of the
National Synchrotron Light Source (Brookhaven National Laboratory), beamline 24-ID-C at the
Advanced Photon Source (Argonne National Laboratory), and beamline 14-1 at Stanford
Synchrotron Radiation Lightsource. X-ray diffraction data were processed using HKL2000
(Otwinowski and Minor, 1997). Crystals of ATAS mutant-inhibitor complexes were isomorphous
with the wild-type ATAS-FSPP complex, belonging to space group P3121 with 4 monomers in
the asymmetric unit.
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Crystal structures of ATAS mutant-ligand complexes were solved by molecular
replacement using Phaser for Molecular Replacement in the CCP4 package with a monomer of
wild-type ATAS (PDB accession code: 4KUX) as a search probe (McCoy et al., 2007). Iterative
cycles of refinement and model building were performed with PHENIX and COOT, respectively
(Adams et al., 2010; Emsley and Cowtan, 2004). Inhibitor, Mg2+ ions, and water molecules were
added to each model in the later stages of refinement.
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Table 3.1. Primers used for ATAS site-directed mutagenesis

S303H

F/Ra
F
R
F

S303D

R
F

Mutation
S303A

N299A
N299V
N299L
N299A/S303A

Q151H
Q151E

a

R
F
R
F
R
F
R
F
R
F
R
F
R
F
R

5'-3'
GAG CTG TGG GCT CAG ACA ACG
CGT TGT CTG AGC CCA CAG CTC
GAG CTG TGG CAT CAG ACA ACG
CGT TGT CTG ATG CCA CAG CTC
GAG CTG TGG GAC CAG ACA ACG
CGT TGT CTG GTC CCA CAG CTC
ATG AGT GGC GCT GAG CTG TGG AGT
ACT CCA CAG CTC AGC GCC ACT CAT
ATG AGT GGC GTT GAG CTG TGG AGT
ACT CCA CAG CTC AAC GCC ACT CAT
ATG AGT GGC CTT GAG CTG TGG AGT
ACT CCA CAG CTC AAG GCC ACT CAT
ATG AGT GGC GCT GAG CTG TGG AGT
ACT CCA CAG CTC AGC GCC ACT CAT
GCT GAG CTG TGG GCT CAG ACA ACG TTG
CAA CGT TGT CTG AGC CCA CAG CTC AGC
CAT GCG GGC ACA CAC GGA C
GTC CGT GTG TGC CCG CAT G
CAT GCG GGC AGA GAC GGA C
GTC CGT CTC TGC CCG CAT G

F = forward primer, R = reverse primer.
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Table 3.2. Data collection and refinement statistics of ATAS mutants
Complex
Beamline
Resolution limits (Å)
Space group
Unit cell parameters a, c (Å)
Total/unique reflections
Redundancy
Rmergea,b
Rpima,d
CC1/2a,e
I/σ(I)a
Completeness (%)a
Reflections used in
work set/test set
Rworkf
Rfreef
Protein atomsg
Solvent atomsg
Metal ionsg
Pyrophosphate ionsg
Phosphate iong
Terpene analoguesg
Glycerol moleculesg
R.m.s. deviations
Bonds (Å)
Angles (deg)
Average B factors (Å2)
Protein
Solvent
Ligands
Ramachandran Plot (%)
Allowed
Additionally allowed
Generously allowed
PDB accession code

S303A
ATAS-4
NSLS X29A
50.0-2.46
P3121
124.13, 203.41

N299A
ATAS-FSPP
NSLS X29A
50.0-1.95
P3121
123.41, 203.46

N299A
ATAS-4
NSLS X29A
50.0-2.04
P3121
123.85, 202.28

922407
(66366)
13.9
0.184 (0.0)c
0.054 (0.401)
0.935 (0.708)
19.7 (2.0)
100.0 (99.9)
66303/2003

2900523
(130703)
22.2
0.125 (0.0)c
0.028 (0.246)
0.977 (0.890)
31.4 (3.6)
100.0 (100.0)
130628/2001

1956559
(114972)
17.0
0.111 (0.0)c
0.033 (0.405)
0.934 (0.707)
24.7 (1.9)
100.0 (100.0)
114883/2006

0.215
0.253
9883
602
12
6
0
4
1

0.162
0.199
9874
1372
12
0
0
4
3

0.203
0.235
9849
999
12
6
0
4
2

0.002
0.6

0.015
1.5

0.003
0.6

51
45
56

36
44
40

42
42
39

94.6
5.4
0.0
5IMI

96.1
3.9
0.0
5IVG

97.8
2.1
0.1
5IMP

(Continued on P64)
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Complex
Beamline
Resolution limits (Å)
Space group
Unit cell parameters a, c (Å)
Total/unique reflections
Redundancy
Rmergea,b
Rpima,d
CC1/2a,e
I/σ(I)a
Completeness (%)a
Reflections used in
work set/test set
Rworkf
Rfreef
Protein atomsg
Solvent atomsg
Metal ionsg
Pyrophosphate ionsg
Phosphate iong
Terpene analoguesg
Glycerol moleculesg
R.m.s. deviations
Bonds (Å)
Angles (deg)
Average B factors (Å2)
Protein
Solvent
Ligands
Ramachandran Plot (%)
Allowed
Additionally allowed
Generously allowed
PDB accession code

N299A/S303A
ATAS-4
APS 24IDC
50.0-2.52
P3121
124.30, 202.63
476896
(61282)
7.8
0.156 (0.0)c
0.085 (0.775)
0.875 (0.589)
14.8 (1.2)
99.9 (99.9)
61228/1990

Q151H
ATAS-FSPP
SSRL 14-1
50.0-2.35
P3121
122.85, 202.52
689724
(73952)
9.3
0.183 (0.0)c
0.063 (0.679)
0.826 (0.490)
17.7 (1.4)
99.9 (100.0)
73914/2007

0.195
0.254
9836
288
12
6
0
4
1

0.211
0.243
9903
705
8
1
3
0
7

0.008
1.1

0.002
0.5

58
52
57

51
50
67

94.1
5.9
0.0
5IMN

95.9
4.1
0.0
5IN8

a

Numbers in parentheses refer to the highest resolution shell of data. bRmerge for replicate reflections, R =
∑|Ih – 〈Ih〉|/∑〈Ih〉; Ih = intensity measure for reflection h, 〈Ih〉 = average intensity for reflection h calculated
from replicate data. cRmerge values higher than 1.000 are reported as 0.000 by HKL2000; this is sometimes
observed for datasets with high redundancy. dRpim= ∑[1/(n-1)]1/2|Ih – 〈Ih〉|/∑〈Ih〉; n is the number of
observations (redundancy). eCC1/2 = στ2/(στ2 + σε2), where στ2 is the true measurement error variance and
σε2 is the independent measurement error variance. fRwork = ∑||Fo| – |Fc||/∑|Fo| for reflections contained in
the working set. Rfree = ∑||Fo| – |Fc||/∑|Fo| for reflections contained in the test set held aside during
refinement (5% of total). |Fo| and |Fc| are the observed and calculated structure factor amplitudes,
respectively. gPer asymmetric unit.
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Results
S303A, S303H, and S303D ATAS. The 2.46 Å-resolution X-ray crystal structure of
S303A ATAS complexed with bicyclic carbocation intermediate analogue 4 is essentially
identical to that of the wild-type ATAS-4 complex, with a root-mean-square (rms) deviation of
0.31 Å for 285 Ca atoms between the two structures (Figure 3.2). Water molecule "w" remains in
the same position observed in the wild-type enzyme despite the loss of the hydrogen bond with
S303, and it remains hydrogen bonded with N213 and N299. Although the conformations of
active site residues are essentially identical between the two structures, the 6-membered ring of 4
bearing the isopropylidene group tends toward a sofa-like conformation slightly different from
the chair-like conformation observed in the wild-type enzyme. This difference may be a
consequence of the lower resolution structure of S303A ATAS, since the structure of the wildtype ATAS-4 complex was determined at 1.95 Å resolution. At 2.46 Å resolution, the position of
the isopropylidene substituent of 4 in the S303 ATAS complex is only moderately well defined in
the electron density map (Figure 3.2a).
The lack of any major structural differences between S303A ATAS and wild-type ATAS
is consistent with similar steady-state kinetic parameters measured for these enzymes (Table 2.3).
However, the mutant enzyme exhibits slightly compromised cyclization fidelity, in that it
generates 88.5% aristolochene (Figure 3.3). Two minor products identified are the cyclization
intermediate germacrene A (9.5%), which reflects the loss of effective general acid catalysis to
reprotonate this initially formed cyclic terpene, and nerolidol (2%), which indicates that the
initially formed farnesyl cation can be immediately quenched by an active site water molecule.
That this quenching reaction can compete, albeit weakly, with the C1-C10 bond-forming reaction
leading to germacrene A suggests that the position and orientation of C10 is slightly
compromised in S303A ATAS. In the structure of the ATAS-FSPP complex (Figure 3.1b), the
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C10 atom of FSPP abuts water molecule "w". Weakening hydrogen bond interactions with water
molecule "w" in S303A ATAS may weaken the template that holds C10 in place. If so, water
molecule "w" is an essential part of the template that governs the conformation of the flexible
substrate.
Although we were unable to crystallize S303H ATAS and S303D ATAS, steady-state
kinetic parameters indicate that the consequences of these sterically-demanding mutations are
much more severe, with approximately 10- and 250-fold reductions in catalytic efficiency (Table
3.3). Interesting, too, is the fact that these mutants generate diminished amounts of aristolochene
(32.9% and 15.8%, respectively). These mutants also generate a greater percentage of the
hydroxylated products nerolidol as well as farnesol, with total hydroxylated product percentages
of 10.5% and 47.4% for S303H ATAS and S303D ATAS, respectively. Nerolidol and farnesol
are generated by the addition of water to the initially formed allylic cation upon FPP ionization.
Increased percentages of these sesquiterpene alcohols generated by S303H ATAS and S303D
ATAS are similarly consistent with defects in the active site template that would otherwise hold
the C1 and C10 atoms of FPP close together for the initial cyclization reaction.
Based on analysis of the active site solvent structure in the ATAS-FSPP complex (Figure
2.1b), the Mg2+C-bound water molecule is located directly over the plane of the incipient allylic
cation that would result from FPP ionization. Although the Mg2+C-bound water molecule appears
to be poised for stereospecific addition to C3 to yield 3R-nerolidol or to C1 to generate farnesol,
chiral GC-MS analysis established that the nerolidol generated by S303D ATAS and other
mutants is a completely racemic mixture of the 3R and 3S stereoisomers. In some fraction of the
mutant proteins, the initially-generated allylic cation must be sufficiently disordered so as to
allow addition of water to either side of the allylic cation in place of the normal electrophilic
cyclization by intramolecular attack on C10. Since the Mg2+C-bound water molecule is closest to
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the C1 and C3 atoms of the farnesyl group in the ATAS-FSPP complex, we suggest that this
water molecule is responsible for the generation of hydroxylated products.
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Figure 3.2. Zoom-in view of ATAS S303A active site. (a) Simulated annealing omit map of the
S303A ATAS-4 complex (chain A, contoured at 3.0 σ). Atoms are color-coded as follows: C =
yellow (protein) or gray (4), O = red, N = blue, P = orange, Mg2+ ions = green spheres, solvent
molecules = red spheres. Hydrogen bonds and metal ion coordination interactions are shown as
black and red dashed lines, respectively; hydrogen bonds with the PPi group are omitted for
clarity. (b) Superposition of the S303A ATAS-4 complex (color-coded as in (a)) with S303, water
molecule w, and aza analogue 4 as observed in the wild-type ATAS-4 complex.
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Figure 3.3. Sesquiterpene product distributions generated by ATAS mutants. The exclusive
formation of aristolochene by the wild-type enzyme was previously reported by Felicetti and
Cane (Felicetti and Cane, 2004).
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Table 3.3. Steady-state kinetics for ATAS mutants.
Mutant
kcat (s-1)
KM (µM)
kcat/KM (M-1s-1)
wild-type
0.027 ± 0.003
0.099 ± 0.05
2.7 x 105
S303A
0.045 ± 0.002
0.12 ± 0.02
3.7 x 105
S303H
0.0013 ± 0.0002
0.061 ± 0.02
2.1 x 104
S303D
0.00041 ± 0.00004
0.36 ± 0.09
1.1 x 103
N299A
0.012 ± 0.0004
0.41 ± 0.06
2.9 x 104
a
N299V
------N299Lb
------N299A/S303A
0.0058 ± 0.0003
0.41 ± 0.09
1.4 x 104
Q151H
0.00063 ± 0.0002
0.042 ± 0.01
1.5 x 104
Q151E
0.0015 ± 0.0006
0.10 ± 0.04
1.5 x 104
a
N299V ATAS is soluble and exists as a dimer in solution, but we were unable to measure the
generation of any terpenoid products. bAlthough N299L ATAS suffers from compromised
thermostability, and its tendency for aggregation hindered the measurement of steady-state kinetic
parameters, this mutant generated sufficient sesquiterpene products for analysis as outlined in
Figure 3.3.
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N299A, N299V, and N299L ATAS. The 1.95 Å-resolution structure of N299A ATAS
complexed with substrate analogue FSPP showed that all residues lining the active site adopt
essentially identical conformations with those in wild-type ATAS-FSPP structure (Figure 3.4).
The void created by substituting N299 with alanine is partially occupied by water molecule ‘w4’,
which corresponds to the former position of the Nδ atom of N299. The orientation of the
isopropylidene group differs slightly from that observed in the wild-type active site. However,
given that 99.5% of the hydrocarbon products generated by N299A ATAS are cyclic, it appears
that the N299A substitution does not significantly perturb the ability to achieve the reaction
geometry required for the 1,10-cyclization reaction.
The 2.04 Å-resolution structure of N299A ATAS complexed with carbocation analogue 4
reveals that the deletion of the N299 carboxamide group results in the binding of two additional
water molecules, "w3" and "w4", in locations corresponding to the positions formerly occupied
by the Oδ and Nδ atoms of N299 (Figure 3.5). Additionally, due to the loss of its hydrogen bond
with N299 and the binding of a new water molecule designated "w3" (water w3 is not observed in
the N299A ATAS-FSPP complex), the side chain of Y61 flips by approximately 90° and makes
van der Waals contacts with 4. The binding conformation of 4 is similar to that observed in the
wild-type enzyme, but the analogue is tilted by approximately 20° so that the isopropylidene
group points toward A299. It is interesting that the conformation of Y61, as influenced by the
N299A substitution, impacts product outcome: mutants in which Y61 is flipped are defective in
the step required to protonate germacrene A. Since Y61 does not act as a general acid during
catalysis of the ionization and cyclization of FPP (the corresponding tyrosine-to-phenylalanine
mutant of Penicillium roqueforti aristolochene synthase exhibits only a minor decrease in the
catalytic efficiency of aristolochene production), this residue can nonetheless influence catalysis
as discussed further in the next section (Felicetti and Cane, 2004).
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Although the N299V ATAS protein was soluble and formed a dimer as indicated by gel
filtration chromatography, no terpene products could be detected from incubation of FPP. We
were also unable to crystallize this mutant. N299L ATAS was similarly difficult to work with,
and was particularly susceptible to aggregation. We were unable to measure steady-state kinetics
from this mutant; upon further investigation, we discovered that its melting temperature of 29.1
˚C was just below the temperature of 30 ˚C at which kinetic assays were performed. We were
able, however, to measure sesquiterpene product arrays generated by incubation of N299L ATAS
with FPP (Figure 3.3). Here, too, the small percentage of nerolidol generated by N299L ATAS is
racemic, indicative of sufficient substrate disorder following ionization to enable addition of
water with equal facility to either side of the allylic cation.
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Figure 3.4. Zoom-in view of N299A ATAS-FSPP active site. (a) Simulated annealing omit map
of the N299A ATAS-FSPP complex (chain A, contoured at 2.5 σ). Atoms are color-coded as
follows: C = yellow (protein) or gray (FSPP), O = red, N = blue, P = orange, Mg2+ ions = green
spheres, solvent molecules = red spheres. Hydrogen bonds and metal ion coordination
interactions are shown as black and red dashed lines, respectively; hydrogen bonds with the PPi
group are omitted for clarity. (b) Superposition of the N299A ATAS-FSPP complex (color-coded
as in (a)) with S303, N299, Y61, water molecule w, and FSPP as observed in the wild-type
ATAS-FSPP complex.
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Figure 3.5. Zoom-in view of N299A ATAS-4 active site. (a) Simulated annealing omit map of
the N299A ATAS-4 complex (chain A, contoured at 3.0 σ). Atoms are color-coded as follows: C
= yellow (protein) or gray (4), O = red, N = blue, P = orange, Mg2+ ions = green spheres, solvent
molecules = red spheres. Hydrogen bonds and metal ion coordination interactions are shown as
black and red dashed lines, respectively; hydrogen bonds with the PPi group are omitted for
clarity. (b) Superposition of the N299A ATAS-4 complex (color-coded as in (a)) with N299, Y61,
water molecule w, and aza analogue 4 as observed in the wild-type ATAS-4 complex.
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N299A/S303A ATAS. The 2.52 Å-resolution structure of the double mutant
N299A/S303A ATAS complexed with carbocation analogue 4 reveals that significant unoccupied
volume is introduced around the mutated side chains, but no ordered water molecules are
observed in the electron density map (Figure 3.6). It is nonetheless likely that this cavity is
occupied by at least 3 water molecules, as observed in the structure of the N299A ATAS-4
complex (Figure 3.5). Active site solvent molecules in the N299A/S303A ATAS-4 complex are
perhaps rendered invisible to crystallographic detection by disordered binding and/or the
moderate resolution of the structure determination.
Interestingly, the mutation of N299 and S303 simultaneously is more synergistic than
additive with regard to germacrene A production, which accounts for 72.5% of all products
formed (Figure 3.3). Thus, the reprotonation of germacrene A in the ATAS mechanism is
severely compromised in the double mutant. Catalytic efficiency (kcat/KM) is diminished
approximately 20-fold compared with wild-type ATAS (Table 3.3). The additional active site
volume introduced by the double mutation also compromises the template function of the active
site, which, while still able to promote the initial C1-C10 bond-forming reaction that generates
germacrene A, is no longer effective in precisely orienting this intermediate for normal
protonation and cyclization to form the eudesmane cation.
In this structure, too, the side chain of Y61 is flipped approximately 90° to accommodate
the isopropylidene group of 4, with which it makes several van der Waals contacts (Figure 3.6).
On the other hand, no van der Waals interactions are observed between Y61 and 4 in the wildtype ATAS-4 complex or the S303A ATAS-4 complex (Figure 3.3). Interestingly, the
conformational change of Y61 is observed in the wild-type enzyme upon the binding of a
stereochemically-incorrect aza analogue – specifically, the enantiomer of 4 – so the
conformational change of Y61 may signal the possibility of an aberrant cyclization cascade.
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Taken together, we suggest that the conformation of Y61 in these mutants significantly influences
the position and conformation of germacrene A. If template features specifically required for
germacrene A cyclization are compromised, then germacrene A cyclization will not proceed.
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Figure 3.6. Zoom-in view of S303A/N299A ATAS-4 active site. (a) Simulated annealing omit
map of the S303A/N299A ATAS-4 complex (chain A, contoured at 3.0 σ). Atoms are colorcoded as follows: C = yellow (protein) or gray (4), O = red, N = blue, P = orange, Mg2+ ions =
green spheres, solvent molecules = red spheres. Hydrogen bonds and metal ion coordination
interactions are shown as black and red dashed lines, respectively; hydrogen bonds with the PPi
group are omitted for clarity. Note that active site water molecules are not observed in this
structure, possibly due to its modest 2.52 Å resolution. (b) Superposition of the S303A/N299A
ATAS-4 complex (color-coded as in (a)) with S303, N299, Y61, and aza analogue 4 as observed
in the wild-type ATAS-4 complex.
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Q151H and Q151E ATAS. The 2.35 Å-resolution structure of Q151H ATAS
cocrystallized with FSPP reveals several surprising features in the active site (Figure 3.7). First,
while water molecule ‘w2’ is absent, the carboxylate group of D84 points away from its usual
orientation to form a hydrogen bond with water ‘w1’, with the Oδ atom of D84 forming a van der
Waals contact with Nε2 of H151. This interaction compromises the metal coordination
environment such that only Mg2+B and Mg2+C are observed; moreover, Mg2+C is no longer
coordinated by D84, but instead drifts to a position approximately 2 Å away where it is
coordinated by 6 water molecules with octahedral geometry in chain A (Figures 3.7a, 3.7b).
Accordingly, this structure represents a snapshot of metal association/dissociation in a terpenoid
cyclase active site.
Second, only one (thiolo)phosphate group is observed in the electron density map of
chains A, C, and D, but the electron density map reveals an intact (thiolo)diphosphate group in
chain B (Figures 3.7c, 3.7d). Some discontinuous, weak electron density peaks (< 3σ) are present
in the active site pocket, but they are not readily interpretable as either the farnesyl group of FSPP
or a derived hydrocarbon product. Possibly, the FSPP molecule was sufficiently reactive under
the conditions of cocrystallization utilized for this variant to yield hydrocarbon and inorganic
(thiolo)diphosphate products. However, we cannot explain why such reactivity would have been
observed in this mutant but not in the wild-type enzyme, or in N299A ATAS (Figure 3.4).
Additionally, we cannot explain the appearance of the tetrahedral anion interpreted as inorganic
(thiolo)phosphate, since neither phosphate nor sulfate were included in the crystallization buffer,
unless the thiolodiphosphate product is susceptible to hydrolysis under the crystallization
conditions utilized for this study.
Regardless of these unusual structural results, Q151H ATAS generates a broad mixture
of aristolochene, germacrene A, farnesol, and racemic nerolidol, with no particularly dominant
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product and a catalytic efficiency only one order of magnitude lower than that of the wild-type
enzyme (Figure 3.3, Table 3.3). As previously concluded for S303A and N299A mutants, the
generation of hydroxylated products farnesol and racemic nerolidol by Q151H ATAS reflects the
quenching of the initially formed farnesyl cation by a nearby water molecule, possibly the Mg2+Cbound water.
A significant change in product distribution is observed for Q151E ATAS (Figure 3.3).
Increased production of germacrene A indicates that the template function of the active site is
compromised, such that germacrene A does not undergo reprotonation to generate the eudesmane
cation. Moreover, the generation of increased percentages of farnesol and racemic nerolidol by
this mutant indicates that the competing rate of premature quenching of the initially formed
farnesyl cation is comparable to the rate of the C1-C10 bond forming reaction.
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Figure 3.7. Zoom-in view of Q151H ATAS active site. (a) Simulated annealing omit map
(contoured at 3.0 σ) of the (thiolo)phosphate ion (Pi) observed in chain A of Q151H ATAS
cocrystallized with the unreactive substrate analogue FSPP (Pi is also observed in the active sites
of chains C and D). (b) Superposition of chain A of Q151H ATAS cocrystallized with FSPP
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(color-coded as in (a)) with Q151, D84, 3 Mg2+ ions, diphosphate group, and aza analogue 4 as
observed in the wild-type ATAS-4 complex. (c) Simulated annealing omit map (contoured at 3.0
σ) of the (thiolo)diphosphate ion (Pi) observed in chain B of Q151H ATAS cocrystallized with
the unreactive substrate analogue FSPP. (d) Superposition of chain B of Q151H ATAS
cocrystallized with FSPP (color-coded as in (a)) with Q151, D84, 3 Mg2+ ions, diphosphate group,
and aza analogue 4 as observed in the wild-type ATAS-4 complex. The orientation of the
diphosphate group has changed in response to changes in Mg2+ ion positions.
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Discussion
A terpenoid cyclase is the archetype of a template-directed enzyme, in which the
particular product(s) generated are a function of the specific conformation of the flexible
isoprenoid substrate imposed by the enzyme active site. In essence, the directions for substrate
folding and the ensuing sequence of carbon-carbon bond-forming reactions are encoded by the
active site contour. Aliphatic and aromatic amino acid side chains that typically define the active
site contour play critical roles in the template function of a terpenoid cyclase. Curiously, polar
side chains occasionally serve this function, too, and such side chains can be hydrogen bonded
with trapped solvent molecules in the enzyme-substrate complex.
The structural and functional studies reported herein represent the first steps in dissecting
structure-function relationships for polar amino acid side chains that contribute to the active site
contour of ATAS, specifically, side chains that form hydrogen bonds with trapped solvent
molecules at the periphery of the active site. Crystal structures of S303A ATAS and N299A
ATAS show that water molecule "w" remains in place despite the deletion of one of its hydrogen
bond interactions (Figures 3.2, 3.4, and 3.5). Only in the crystal structure of the double mutant,
S303A/N299A ATAS, are no ordered solvent molecules observed (Figure 3.6), although this is
probably a consequence of the slightly more modest resolution (2.52 Å) of the crystal structure.
The Q151H substitution replaces one polar side chain with a larger polar side chain, which results
in a ~2 Å movement of Mg2+C (no longer coordinated by protein residues, but instead by 6 water
molecules), the conformational change of former Mg2+C ligand D84, and the steric displacement
of water molecule w2.
Interestingly, crystal structures of N299A ATAS and S303A/N299A ATAS reveal that
deleting the N299–Y61 hydrogen bond results in a ~90˚ rotation of the Y61 side chain. The side
chain of Y61 is located in the region of the active site that accommodates the terminal isoprenoid
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moiety of FPP. Thus, Y61 plays an important role in directing the stereochemistry of C1-C10
bond formation and accordingly the stereochemistry of the derived isopropylidene group.
Mutagenesis of N299, which forms a hydrogen bond with Y61, results in some loss of
conformational control, such that the cyclization reaction is mostly aborted upon formation of
germacrene A. This indicates that the 90˚ rotation of the Y61 side chain hinders the ability of
germacrene A to be reprotonated by a general acid to enable eudesmane cation formation. The
altered binding orientations of analogue 4 in the active site of N299A ATAS (Figure 3.5) and
S303A/N299A ATAS (Figure 3.6) presumably reflect the loss of conformational control in the
active sites of these mutant enzymes, which in turn leads to increased product diversity (Figure
3.3).
It is notable that the ATAS mutants studied generate only farnesol and nerolidol as
hydroxylated products, indicating that water molecules "w", "w1", and "w2" (and "w3" and "w4"
in Q151H ATAS) are located in positions such that they cannot readily react with carbocation
intermediates. These catalytically inert water molecules appear to serve a more important
function as part of the active site template, making van der Waals interactions with the substrate
and carbocation intermediates. Active site water molecules have been observed from time to time
in the closed active site conformations of terpenoid cyclases containing bound analogues, such as
bornyl diphosphate synthase and ATAS (Whittington et al., 2002). Thus, active site water is not
inherently deleterious to catalysis by a terpenoid cyclase. The catalytic power of a terpenoid
cyclase is not only rooted in its ability to direct the formation of myriad cyclization products from
a common substrate, but also its ability to direct – or in this case, to suppress – the reactivity of
water as a solvent for organic synthesis.
How, then, does a terpenoid cyclase activate a water molecule for catalysis? Simple
examples of such reactivity are evident in the generation of farnesol and racemic nerolidol by the
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ATAS mutants reported herein: a Mg2+C-bound water molecule is closest to the incipient allylic
cation and is probably the most likely nucleophile, based on the crystal structure of the ATASFSPP complex (Figure 3.1b). If the C1-C10 bond forming step is compromised by mutagenesis,
e.g., by altering the active site contour so that C10 is improperly oriented and/or the allylic cation
is subject to conformational disorder upon its formation, then the Mg2+C-bound water molecule
might be able to quench the newly formed farnesyl cation at C1 or C3.
When the allylic cation is quenched at C3 to form nerolidol, a racemic mixture results,
indicating that the addition of water takes place in essentially an achiral environment. However,
simple acid- or divalent metal ion-catalyzed solvolysis of FPP normally generates a 3–4:1
mixture of nerolidol to farnesol (George-Nascimento et al., 1971; Cramer and Rittersdorf, 1967),
and this ratio is not observed for any of the ATAS mutants studied (Figure 3.3). This suggests
that the allylic cation is quenched before complete release from the ATAS active site. It is
possible, too, that FPP may bind to ATAS mutants that generate nerolidol and farnesol in an
alternative conformation to that observed in the active site of the wild-type enzyme or N299A
ATAS (Figure 4), and the alternative conformation may facilitate quenching of the allylic cation
by Mg2+C-bound water or perhaps even by an alternative water molecule.
The Mg2+C-bound water molecules may mediate proton exchange between the active site
and bulk solvent, through which a solvent-derived deuteron is utilized to protonate the 6,7-double
bond in the germacrene A intermediate (Miller et al., 2008). However, neither a Mg2+C-bound
water molecule nor the substrate diphosphate group is suitably oriented to protonate the
established re-face of the 6,7-double bond of the intermediate germacrene A, as is evident from
the position of the corresponding 6,7-double bond in the ATAS-FSPP complex. This suggests
that the germacrene A intermediate may undergo reorientation in the active site so as to enable
reprotonation and formation of the eudesmane cation. The structure of the complex between wild84

type ATAS and the bicyclic aza analogue 4 suggests that the final stereospecific deprotonation
generating the product aristolochene could be mediated by the PPi counterion.
Curiously, some cyclases contain polar and even charged residues in prominent active
site positions. For example, methylisoborneol synthase contains a negatively charged glutamate
residue, E193, at the base of its active site. While E193 was initially hypothesized to orient an
active site water molecule to quench the final carbocation intermediate, E193A, E193D, and
E193L mutants exhibit no discernible changes in the yield of the hydroxylated product (Koksal et
al., 2012). In contrast, the X-ray crystal structure of hedycaryol synthase accompanied by
mutagenesis experiments suggests that D82 in the upper wall of the active site plays a role in
activating a water molecule that quenches the final carbocation intermediate (Baer et al., 2014).
Similarly, the crystal structure of cineole synthase reveals that N338 hydrogen bonds with a water
molecule at the base of the active site cleft; N338I cineole synthase does not generate
hydroxylated products, thereby suggesting that N338 and its hydrogen bonded water molecule are
critical for catalysis in the wild-type enzyme (Kampranis et al., 2007).
In conclusion, the current study provides several key lessons regarding the role of water
as both a solvent and a reagent for organic synthesis by a terpenoid cyclase. First, the Mg2+Cbound water molecule is the active site solvent molecule closest to the incipient allylic cation
formed by FPP ionization. The reactivity of this bound solvent molecule might be facilitated by
disorder of the farnesyl cation that results from the defects introduced into the active site contour
of the mutant. Although the intrinsic nucleophilicity of this water would be reduced by
complexation to Mg2+, the latent reactivity of metal-bound water might be unmasked by the
weakening of metal coordination or by the action of an unidentified proton acceptor. Such latent
reactivity of Mg2+C-bound water may similarly be responsible for the generation of farnesol
and/or nerolidol by other sesquiterpene cyclases as well. Second, terpenoid cyclase active site
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cavities are not always completely anhydrous when they form enzyme-substrate complexes and
may occasionally contain trapped water molecules. These water molecules can be utilized in
catalysis only if they are positioned to add to the empty 2p orbitals of carbocation intermediates.
Otherwise, such water molecules simply comprise part of the active site contour, and as such will
help govern the conformation of the flexible substrate and carbocation intermediates. Finally, in
enzymes that have evolved to use water as a reagent for organic synthesis, some such as
methylisoborneol synthase have no clearly defined general base to orient or activate a catalytic
water molecule, and others such as hedycaryol synthase or cineole synthase do have a welldefined general base. Future studies with ATAS and other terpenoid cyclases will continue to
illuminate the complexities of water management in terpenoid biosynthesis.
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CHAPTER 4: Crystal Structure of Unliganded Germacradien-4-ol synthase

The content of this chapter was originally published in Biochemistry. It is adapted here with
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Introduction
Streptomyces are a large source of antibiotics, including aristeromycin, an inhibitor of
purine synthesis and S-adenosylhomocystein hydrolase (Kusaka et al., 1968). Nakano et al.
reported the sesquiterpene gene of (-)-germacradien-4-ol synthase (GdolS) in Streptomyces
citricolor (Nakano et al., 2011). To date, the function of this compound in Streptomyces citricolor
is not known yet. (-)-germacradien-4-ol is a also found in scots pine needles, and is utilized by
larvae of pine sawflies to repel predator, which causes defoliation of pine trees (Kopke et al.,
2008).
The bacterial sesquiterpene synthase (-)-germacradien-4-ol synthase (GdolS) converts
farnesyl diphosphate (FPP, 1) into the macrocyclic terpene alcohol (-)-germacradien-4-ol (2)
(Figure 4.1). Unlike many terpene cyclases that are solely responsible for synthesizing
hydrocarbon product(s) and depend on tailoring enzymes for oxygen insertion, GdolS completes
2 or even more enzymatic transformations in one catalysis, expanding the potential chemical
space of the biosynthetic pathway. The enzyme exerts significant control over a catalytic water
molecule, which quenches the final carbocation intermediate of the reaction cascade with high
stereospecificity and regiospecificity (Nakano et al., 2011). Together with Aspergillus terreus
aristolochenes synthase, GdolS is one of the few high-fidelity terpene cyclases that exclusively
generate a single product (Felicetti and Cane, 2004).
GdolS serves as a great model system in understanding of the molecular basis of a
highly-specific terpene cyclization trajectory involving the activation of a water molecule.
Herein, we report the crystal structure of unliganded GdolS at 1.5 Å, revealing a characteristic αhelical fold of class I terpene cyclases with 2 metal binding motifs flanking the active site. A
close examination of active site residues does not reveal a direct binding partner of the
catalytically active water molecule. Complemented with biochemical study reported elsewhere,
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we propose that quenching of the final carbocation intermediate is completed by a water molecule
from bulk solvent.
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Figure 4.1. Possible mechanism for the germacradien-4-ol synthase (GdolS).
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Materials and Methods
Initially contained on a pET-16b vector (Novagen), the gene encoding GdolS was cloned
onto a pET-28a vector, which improved the solution behavior of the expressed protein by
decreasing protein precipitation at high concentrations (possibly due to a shorter His-tag). To
facilitate crystallization by reducing protein flexibility, the E248A mutation was made based on
sequence analysis using the Surface Entropy Reduction Server
(http://services.mbi.ucla.edu/SER/) (Goldschmidt et al., 2007). Corresponding forward and
reverse primers were: 5’-CTG CTC CAC CGC AGA GGC CTG-3’ and 5’-CAG GCC TCT
GCG GTG GAG CAG-3’, respectively (boldface indicates the mutated codon). The E248A
mutant was expressed using the Escherichia coli BL21-CodonPlus (DE3)-RIL strain (Novagen).
Briefly, 6 × 1L LB medium containing 50 µg/mL kanamycin and 34 µg/mL chloramphenicol
were inoculated with 5 mL starting culture and grown at 37 °C with aeration. Cells were induced
with 0.5 mM isopropyl β-D-1-thiogalactopyranoside at 16 °C when optical density at 600 nm
reached 0.8-1.0. After expression for 18 h, cells were pelleted by centrifugation.
The cell pellet was resuspended in Ni-NTA (QIAGEN) wash buffer [50 mM K2HPO4 (pH
7.7), 300 mM NaCl, 10% (v/v) glycerol, 3 mM tris(2-carboxyethyl)-phosphine hydrochloride
(TCEP)]. Cells were lysed by sonication for 10 min at amplitude of 50, with a setting of 1 s on
and 2 s off. Cell debris was discarded after centrifugation, and supernatant was loaded on a NiNTA column. Protein was eluted with a 0–400 mM imidazole gradient in Ni-NTA wash buffer.
The most active fractions from Ni-NTA column were combined and concentrated, and
subsequently loaded onto a 10-mL HiTrap Q HP column (GE Healthcare) after exchange to Q
wash buffer [10 mM Tris (pH 8.0), 10 mM NaCl]. Elution was carried out with a 0–500 mM
NaCl gradient in Q wash buffer. Fractions were analyzed by SDS-PAGE, and most active ones of
which were concentrated and loaded onto a HiLoad Superdex 200 PG column pre-equilibrated
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with 137 mM sodium chloride, 2.7 mM potassium chloride, 10 mM disodium hydrogen
phosphate, 1.8 mM potassium dihydrogen phosphate, 5% (v/v) glycerol (pH 7.4). Fractions were
analyzed by SDS-PAGE, the most active of which were combined and concentrated to 5.5
mg/mL, and stored at -80 °C.
For crystallization, GdolS was treated with trypsin for 10 min at room temperature prior
to setting up crystallization trays (molar ratio of GdolS:trypsin = 1000:1). Crystallization was
achieved by the sitting-drop vapor diffusion method at room temperature. Typically, a 1-µL drop
of protein solution [5 mg/mL GdolS, 137 mM sodium chloride, 2.7 mM potassium chloride, 10
mM disodium hydrogen phosphate, 1.8 mM potassium dihydrogen phosphate, 5% (v/v) glycerol
(pH 7.4)] was added to a 1-µL drop of precipitant solution [0.1 M Tris (pH 8.5), 2.0 M
ammonium sulfate (Hampton Research)] and equilibrated against an 80-µL reservoir of
precipitant solution. Crystals generally formed within one week.
After growing to maximum dimensions, crystals of unliganded GdolS was transferred to
a cryoprotectant solution (25% glycerol, 75% mother liquor) and flash-cooled in liquid nitrogen.
X-ray diffraction data to 1.50 Å resolution were collected at beamline 4.2.2 of the Advanced
Light Source (Lawrence Berkeley National Laboratory) and were indexed and integrated with
Denzo in HKL2000, and scaled with SCALA (Evans 2006; Otwinowski and Minor, 1997).
Crystals of the unliganded protein belonged to space group P21, unit cell paramters a = 51.4 Å, b
= 74.1 Å, c = 82.5 Å; with 2 monomers in the asymmetric unit, the Matthews coefficient VM =
2.1 Å3/Da (42% solvent content). Although extensive efforts were made to crystallize GdolS in
the closed conformation stabilized by Mg2+ ions and a bound PPi anion or bisphosphonate ligand,
all attempts failed.
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The crystal structure of unliganded GdolS was solved by molecular replacement using
Phaser for Molecular Replacement in the CCP4 package with a monomer of GdolS structure
solved at lower resolution, which was solved with pentalenene synthase (PDB accession code:
1PS1) as a search probe in the same manner (Lesburg et al., 1997; McCoy et al., 2007). Iterative
cycles of refinement and manual adjustment of the model were performed with PHENIX and
COOT, respectively (Adams et al., 2010; Emsley and Cowtan, 2004). Water molecules were
added to the model in the later stages of refinement. The following disordered segments were
characterized by broken or missing electron density and accordingly were omitted from the final
model: T158-Q161 and S227-V232 (chain A); and M1-T5, G160-Q161, and A224-D231 (chain
B). Final refinement statistics are recorded in Table 4.1.
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Results
GdolS adopts the characteristic alpha-helical fold of a class I terpenoid synthase, as first
observed in the crystal structure of avian farnesyl diphosphate synthase (Tarshis et al., 1994).
GdolS crystallizes as a isologous dimer in the asymmetric unit through the interactions of helices
E, F, H, and I. As often observed for dimeric terpenoid cyclases (Rynkiewicz et al., 2001), the
active sites of the GdolS dimer are oriented in an antiparallel fashion (Figure 4.2).
Sequence alignments with other terpene cyclases show that two metal binding motifs
D80DQFD and N218DVRSFAQE are conserved (boldface indicates presumptive metal ligands),
and the crystal structure of GdolS shows that these segments flank the mouth of the active site on
helices D and H, respectively. While the penultimate residue in the second metal binding motif is
usually an arginine or a lysine residue, GdolS has a glutamine at this position. The function of
this residue is to hydrogen bond with the substrate diphosphate group, so it is interesting to note
the substitution of the shorter, uncharged side chain for the longer, positively charged side chain
that is normally conserved for this function in other cyclases (Yamada et al., 2011). An omit
electron density map showing the metal-binding motifs in unliganded GdolS is shown in Figure
4.3.
The size of the GdolS active site is comparable to that of other sesquiterpene cyclases,
approximately 15 Å deep and 10 Å wide. The active site is predominantly nonpolar with a
contour defined by aliphatic and aromatic side chains. Curiously, although GdolS utilizes a water
molecule to quench the final carbocation intermediate in the cyclization cascade, the active site
does not contain any polar side chains that could readily serve as a general base to facilitate the
reactivity of a trapped water molecule. In the structure of the open active site conformation
presented here, a number of ordered solvent molecules are observed in the GdolS active site.
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However, it is unclear as to whether any of these water molecules play specific structural or
catalytic roles.

95

Figure 4.2. Structure of the GdolS-E248A monomer (left) and dimer (right). The aspartate-rich
and NSE metal-binding segments are colored red and orange, respectively. The position of the
E248A substitution that enabled crystallization is indicated.
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Figure 4.3. Simulated annealing omit map of metal binding motifs. Omit map is calculated for
the metal-binding segments D80DQFD and N218DVRSFAQE in GdolS (wall-eyed stereoview
contoured at 2.5σ).
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Table 4.1. Data collection and refinement statistics of GdolS
Structure
Resolution limits (Å)
Space group
Unit cell parameters
a, b, c (Å)
α, β, γ (˚)
Total/unique reflections
Redundancya
Rmergea,b
Rpimb
CC1/2
I/σ(I)a
Completeness (%)a
Reflections used in
work set/test set
Rworkc
Rfreec
Protein atomsd
Solvent atomsd
Sulfate ionsd
R.m.s. deviations
Bonds (Å)
Angles (deg)
Average B factors (Å2)
Main chain
Side chain
Solvent
SO4- anion
Ramachandran Plot (%)
Allowed
Additionally allowed
Generously allowed
Disallowed

Unliganded GdolS
55.1-1.50
P21
51.4, 74.1, 82.5
90.0, 91.7, 90.0
346240/98277
3.5 (3.2)
0.070 (0.978)
0.044 (0.629)
0.998 (0.588)
11.6 (1.2)
99.4 (99.8)
98143/1994
0.157
0.200
4977
658
10
0.015
1.3
21
24
38
76
96.6
3.4
0.0
0.0

a

Numbers in parentheses refer to the highest resolution shell of data. bRmerge for replicate
reflections, R = ∑|Ih – 〈Ih〉|/∑〈Ih〉; Ih = intensity measure for reflection h; and 〈Ih〉 = average
intensity for reflection h calculated from replicate data. cRwork = ∑||Fo| – |Fc||/∑|Fo| for reflections
contained in the working set. Rfree = ∑||Fo| – |Fc||/∑|Fo| for reflections contained in the test set held
aside during refinement (5% of total). |Fo| and |Fc| are the observed and calculated structure factor
amplitudes, respectively. dPer asymmetric unit.
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CHAPTER 5: Structure and function of fusicoccadiene synthase, a hexameric
bifunctional diterpene synthase

The content of this chapter was originally published in ACS Chem. Biol. It is adapted here with
permission from the publisher: Reprinted with permission from M. Chen, W. K. W. Chou, T.
Toyomasu, D. E. Cane, and D. W. Christianson. Structure and function of fusicoccadiene
synthase, a hexameric bifunctional diterpene synthase. ACS Chem. Biol., 2016, 11, 889-899.
Copyright 2016 American Chemical Society.
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Introduction
Fusicoccin A is a C20 diterpene glucoside containing an unusual tricyclic 5-8-5 ring
system (Figure 5.1) (Ballio et al., 1964; Ballio et al., 1968; Barrow et al., 1968). This phytotoxin
is generated by the fungal pathogen Phomopsis amygdali and causes constriction canker, a plant
disease first discovered in New Jersey peach orchards in the 1930's and subsequently identified in
Georgia and Maryland orchards (Daines et al., 1958; Lalancette and Polk, 2000; Weaver, 1951).
More recently, however, fusicoccin A has been explored in new approaches to cancer
chemotherapy, since this novel diterpene exhibits promising antitumor properties (de Vries-van
Leeuwen et al., 2010). Much of the biological activity of fusicoccin A derives from its ability to
mediate protein-protein interactions involving the 14-3-3 protein (Bunney et al., 2003; de Boer
and de Vries-van Leeuwen, 2012; Milroy et al., 2013). Additionally, fusicoccin A blocks the
proliferation and migration of glioblastoma cells by inhibiting focal adhesion kinase, which
mediates the aggressive invasive phenotype of human gliomas (Bury et al., 2013).
Fusicoccadiene, the hydrocarbon precursor of fusicoccin A, is generated by a bifunctional
diterpene synthase (Toyomasu et al., 2007). Unlike structurally characterized plant diterpene
synthases that exhibit αβγ domain architecture (Koksal et al., 2011; Koksal et al., 2011; Zhou et
al., 2012), and bacterial diterpene synthases that adopt a single α domain fold (α, β, and γ domain
nomenclature is outlined by Oldfield) (Cao et al., 2010; Janke et al., 2014; Liu et al., 2014),
fusicoccadiene synthase from P. amygdali (PaFS) is unique in that it is expected to adopt αα
domain architecture: the C-terminal a domain catalyzes the isoprenoid chain elongation reaction
that generates GGPP, which is then cyclized by the N-terminal a domain to form fusicocca2,10(14)-diene (Figure 5.1). Divalent metal ions are essential for catalysis by PaFS, and the
amino acid sequence contains signature metal binding motifs: the C-terminal domain contains
two aspartate-rich DDXX(D,N) motifs characteristic of a chain elongation enzyme, and the N100

terminal domain contains one DDXXD motif and one NSE/DTE motif, characteristic of a cyclase
(Aaron and Christianson, 2010; Chen et al., 1994). The overall sequence identity between the Nand C-terminal domains is 19%.
The purpose of the current study is to establish a structural context for understanding
catalysis by PaFS, including an unusual transannular proton transfer proposed for the cyclization
mechanism (Toyomasu et al., 2009). We report that PaFS is an allosteric hexamer that exhibits
cooperativity in the cyclization of GGPP, and it can also utilize GPP and FPP as aberrant
substrates. X-ray crystal structures of the individual catalytic domains allow us to construct a
plausible model of the full-length PaFS hexamer based on small-angle X-ray scattering data.
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Figure 5.1. Fusicoccadiene synthase from P. amygdali (PaFS). Geranylgeranyl diphosphate
(GGPP) is generated from one molecule of dimethylallyl diphosphate (DMAPP) and three
molecules of isopentenyl diphosphate (IPP) in the C-terminal α domain (blue box), and GGPP is
cyclized in the N-terminal α domain to form fusicocca-2,10(14)-diene (red box). Further
biosynthetic modifications (green) yield the phytotoxin fusicoccin A.
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Materials and Methods
Protein expression and purification. Originally carried on a pGEX-4T-3 vector (GE
Healthcare), the gene of full-length PaFS was subcloned using forward and reverse primers 5'–
GCC GCC GCT CAT ATG GAG TTC AAA TAC TCG–3' and 5'–GGC TGC AGC GGA TCC
TCA GAC TCG GA–3', respectively. We also prepared deletion constructs containing solely the
N-terminal or C-terminal domains (general domain boundaries were inferred from
straightforward amino acid sequence alignments, taking into account typical microbial terpene
synthase domain lengths). We first prepared the construct containing residues 1-350 of the Nterminal domain, designated "PaFS350", for crystallization trials and enzyme activity assays. After
finding that this construct would not form crystals suitable for structure determination, we
prepared the truncated construct containing residues 1-344, designated "PaFS344", for
crystallization and structure determination. The forward and reverse primers used for subcloning
PaFS344 were 5'–GCC GCC GCT CAT ATG GAG TTC AAA TAC TCG–3' and 5'–CGG AGC
TCG AAT TCG GAT CCT TAC AGT CCT TGA CGC ATC C–3', respectively. The forward and
reverse primers used for cloning PaFS350 were 5'–GCC GCC GCT CAT ATG GAG TTC AAA
TAC TCG–3' and 5'–GGC GGC TGC GGA TCC TTA ACA TGA CTC CAA AGA–3',
respectively. As for the C-terminal domain, the construct designated "PaFSCT" (residues 390-719)
was prepared using forward and reverse primers 5'–GAT CCG CAT ATG CTG AGC ACT GG–
3' and 5'–GGC TGC AGC GGA TCC TCA GAC TCG GA–3', respectively. All DNA constructs
were inserted into a pET-28a vector (Novagen) encoding an N-terminal His-tag. The resulting
clones were confirmed at the DNA sequencing facility at the Perelman School of Medicine,
University of Pennsylvania.
All four constructs were expressed using the Escherichia coli BL21(DE3)RIL-CodonPlus
strain (Novagen). Briefly, 6 × 1L LB medium containing 50 µg/mL kanamycin and 34 µg/mL
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chloramphenicol were inoculated with a 5 mL starting culture and grown at 37 °C with aeration.
Cells were induced with 0.1-0.5 mM isopropyl β-D-1-thiogalactopyranoside at 16 °C when the
optical density at 600 nm reached 0.8-1.0. After expression for 18 h, cells were pelleted by
centrifugation.
For each construct, the cell pellet was resuspended in Ni-NTA (QIAGEN) wash buffer
[50 mM K2HPO4 (pH 7.7), 300 mM NaCl, 10% (v/v) glycerol, 3 mM tris(2-carboxyethyl)phosphine hydrochloride (TCEP)]. Cells were lysed by sonication for 10 min at an amplitude of
50-70, with a setting of 1 s on and 2 s off. Cell debris was discarded after centrifugation, and
supernatant was loaded on a Ni-NTA column. Protein was eluted with a 0-400 mM imidazole
gradient in Ni-NTA wash buffer. Due to additional impurities present in the PaFS344 preparation,
this construct was additionally purified using a 10-mL HiTrap Q HP column (GE Healthcare)
after exchange to Q wash buffer [10 mM Tris (pH 8.0), 10 mM NaCl]. Elution was performed
with a 0-500 mM NaCl gradient in Q wash buffer. Fractions were analyzed by SDS-PAGE, and
the most active ones were combined, concentrated, and loaded onto a size-exclusion column (GE
Healthcare) pre-equilibrated with 50 mM Tris (pH 7.9), 300 mM NaCl, 10% (v/v) glycerol, and 3
mM TCEP. The final protein sample was 98% pure based on SDS-PAGE analysis and was
concentrated to 12-34 mg/mL.
Crystallization and structure determination of the C-terminal chain elongation
domain, PaFSCT. Although extensive efforts were made to crystallize full-length PaFS, all
attempts failed. We hypothesized that the polypeptide linker between the two a domains of fulllength PaFS might be excessively flexible, thereby hindering crystallization, so we pursued an
alternative strategy in which we crystallized the individual N-terminal and C-terminal domains
prepared as described above. Crystallization of the ligand-bound C-terminal domain PaFSCT was
achieved by the sitting-drop vapor diffusion method at 4 °C. Typically, a 1-µL drop of protein
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solution [12 mg/mL PaFSCT, 50 mM Tris (pH 7.9), 300 mM NaCl, 10% (v/v) glycerol, 3 mM
TCEP, 5 mM MgCl2, 50 mM pamidronate (Sigma-Aldrich)] was added to a 1-µL drop of
precipitant solution [0.01 M CoCl2, 0.1 M sodium acetate (pH 4.6), 1.0 M 1,6-hexanediol
(Hampton Research)] and equilibrated against a 70-µL reservoir of precipitant solution. Crystals
generally formed in 2-3 weeks.
The unliganded form of PaFSCT was crystallized by adding a 1-µL drop of protein
solution [12 mg/mL PaFSCT, 50 mM Tris (pH 7.9), 300 mM NaCl, 10% (v/v) glycerol, 3 mM
TCEP] to a 1-µL drop of precipitant solution [1.5 M ammonium phosphate, 0.1 M Tris (pH 8.5)
(Hampton Research)] and equilibrating it against a 70-µL reservoir of precipitant solution.
Crystals generally formed in 2-3 weeks.
After growing to maximum dimensions, crystals of liganded and unliganded PaFSCT were
transferred to a cryoprotectant solution (26% [50% PEG 400, 50% 2-methyl-2,4-pentanediol],
74% mother liquor) and flash-cooled in liquid nitrogen. X-ray diffraction data were collected at
beamline X29A of the National Synchrotron Light Source (Brookhaven National Laboratory) and
were processed using HKL2000 (Otwinowski and Minor, 1997). Crystals of the unliganded
protein belonged to space group P321, unit cell paramters a = b = 104.9 Å, c = 140.5 Å; with 2
monomers in the asymmetric unit, the Matthews coefficient VM = 3.0 Å3/Da (59% solvent
content). Crystals of the liganded protein belonged to space group C2221, unit cell parameters a =
103.6 Å, b = 216.1 Å, c = 129.2 Å; with 3 monomers in the asymmetric unit, VM = 3.3 Å3/Da
(63% solvent content).
The crystal structure of liganded PaFSCT was solved by molecular replacement using
Phaser for Molecular Replacement in the CCP4 package with a monomer of human GGPP
synthase (PDB accession code: 2Q80) as a search probe (Kavanagh et al., 2006; McCoy et al.,
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2007). Iterative cycles of refinement and manual adjustment of the model were performed with
PHENIX and COOT, respectively (Adams et al., 2010; Emsley and Cowtan, 2004). Pamidronate,
Co2+ ions, and water molecules were added to the model in the later stages of refinement. The
following disordered segments were characterized by broken or missing electron density and
accordingly were omitted from the final model: S521 and D578-P582 (chain A), S521-Q523
(chain B), and H639-R642 (chain C). Final refinement statistics are recorded in Table 5.1.
The crystal structure of unliganded PaFSCT was solved by molecular replacement in
similar fashion using a monomer of the liganded PaFSCT structure as a search probe. Iterative
cycles of refinement and manual adjustment of the model were performed with PHENIX and
COOT, respectively (Adams et al., 2010; Emsley and Cowtan, 2004). Water molecules were
added to the model in the later stages of refinement. The following disordered segments were
characterized by broken or missing electron density and accordingly were omitted from the final
model: S517-E520 and V611-E627 (chain A), and A518-E520 and S612-G628 (chain B). Final
refinement statistics are recorded in Table 5.1.
Crystallization and structure determination of the N-terminal cyclase domain,
PaFS344. Initial crystallization of PaFS344 was achieved by the sitting-drop vapor diffusion
method at 4 °C. Typically, a 1-µL drop of protein solution [34 mg/mL PaFS344, 50 mM Tris (pH
7.9), 300 mM NaCl, 10% (v/v) glycerol, 3 mM TCEP, 5 mM MgCl2, 30 mM pamidronate
(Sigma-Aldrich)] was added to a 1-µL drop of precipitant solution [0.1 M sodium acetate (pH
4.8), 1.75 M sodium formate, 0.25 M magnesium formate] and equilibrated against a 70-µL
reservoir of precipitant solution. Crystals generally appeared within 2-3 weeks. After growing to
maximum dimensions, crystals were transferred to cryoprotectant solution (26% [50% PEG 400,
50% 2-methyl-2,4-pentanediol], 74% mother liquor) and flash-cooled in liquid nitrogen.
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These crystals diffracted X-rays to 2.3 Å resolution at the synchrotron and belonged to
space group P3221, unit cell parameters a = b = 143.3 Å, c = 118.3 Å; with 2 molecules in the
asymmetric unit, VM = 4.2 Å3/Da (70.5% solvent content). However, deviations from ideal
intensity statistics indicated a significant twinning fraction of 41%, which would hinder de novo
phasing efforts. Accordingly, crystallization conditions were systematically modified with the
goal of generating an alternative crystal form. Specifically, buffer components of PaFS344
solutions were optimized through the ThermoFluor assay to find conditions under which the
protein would be more stable, reasoning that such conditions might facilitate the formation of an
alternative crystal form.
We successfully identified conditions and a procedure that yielded improved crystals. A
protein solution of 27 mg/mL PaFS344, 30 mM tricine (pH 7.9), 256 mM KCl, 3 mM TCEP, and
10% glycerol was incubated with 8 mM MnCl2 and 1.3 mM neridronate for 1 h. Immediately
prior to setting up crystallization trays, porcine elastase (1:6000 molar ratio with PaFS344) was
added to the protein solution to enable in situ limited proteolysis in drops. Addition of elastase
slowed down crystal growth, and we reasoned that proteolytic nicking might facilitate
crystallization (Dong et al., 2007). Crystallization of liganded PaFS344 was performed at 4 °C by
the sitting-drop vapor diffusion method using an Innovadyne Nanodrop Express crystallization
robot. Equal volumes (900 nL) of protein and precipitant solution [1.05 M sodium formate, 0.075
M manganese formate, 0.1 M sodium acetate (pH 4.4)] were equilibrated against a 50-µL
reservoir of precipitant solution. Crystals appeared within 4-6 weeks and grew to maximal
dimensions approximately 1 week after they initially appeared. Crystals were subsequently
transferred to cryoprotectant solution (28% [50% PEG 400, 50% 2-methyl-2,4-pentanediol], 72%
mother liquor) and flash-cooled in liquid nitrogen.
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X-ray diffraction data from these new crystals of PaFS344 were collected at the Stanford
Synchrotron Radiation Lightsource, beamline 14-1. Crystals belonged to space group P3221, unit
cell parameters a = b = 142.6 Å, c = 117.6 Å; with 2 molecules in the asymmetric unit, V M = 4.1
Å3/Da (70% solvent content). Analysis of intensity statistics indicated a lower twinning fraction
of 22%, which facilitated phasing through single-wavelength anomalous diffraction (SAD) of the
Mn2+ ions.
For SAD phasing, a dataset to 3.0 Å resolution was collected at the Mn peak wavelength
(1.89166 Å) and processed with HKL2000. Initially, 4 Mn sites were identified by ShelxD from
HKL2MAP through single-wavelength anomalous diffraction, and were used for search and
refinement of 4 additional Mn sites (Pape and Schneider, 2004). Solvent flattening and initial
polyalanine model building yielded a 50% complete trace of the polypeptide chain using ShelxE
from HKL2MAP (Pape and Schneider, 2004), which was subsequently used as input for
Phenix.autobuild to generate a 90% complete model. Following manual model adjustment and
registration of the amino acid sequence using COOT (Emsley and Cowtan, 2004), this model was
used as the search probe for molecular replacement calculations with a 2.5 Å resolution dataset
collected at a wavelength of 1.18076 Å from the same crystal. Iterative model adjustment and
refinement were performed with COOT and PHENIX, respectively (Adams et al., 2010; Emsley
and Cowtan, 2004). The twin law (-h, -k, l) was determined using Phenix.xtriage and
incorporated at the beginning of refinement. Refinement statistics are recorded in Table S1.
Segments characterized by uninterpretable broken or missing electron density were omitted from
the final model as follows: H97–A134 and F165–E175 in chain A, and H97–R133 and Q173–
H174 in chain B. These segments could be disordered and/or clipped by the protease added to
facilitate crystallization.
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The refined 2.5 Å resolution structure of the PaFS344-Mn2+3-neridronate complex served
as a molecular replacement probe to solve the 2.3 Å-resolution structure of the PaFS344-Mg2+3pamidronate complex from highly twinned crystals. The twin law (-h,-k, l) was determined using
Phenix.xtriage, and refinement and model building was performed using PHENIX and COOT,
respectively (Adams et al., 2010; Emsley and Cowtan, 2004). Refinement statistics are recorded
in Table 5.1. Segments characterized by uninterpretable broken or missing electron density were
omitted from the final model as follows: H97–A134 and R172–E175 in chain A, and E103–V129
and Q173–H174 in chain B. Since these polypeptide segments in the protease-free PaFS344Mg2+3-pamidronate complex generally correlate with those observed in the protease-treated
PaFS344-Mn2+3-neridronate complex, these segments are likely to be inherently disordered since
protease treatment does not induce significant additional disorder.
Enzyme activity measurements. Cyclization activity assays on a 100-µL scale were
conducted in triplicate, as typically performed in our laboratory with other terpenoid cyclases (Li
et al., 2014), using 7.5–75 nM full-length PaFS or PaFS350 in assay buffer [25 mM HEPES (pH
8.0), 200 mM NaCl (omitted for PaFS350 assays), 5 mM MgCl2]. Concentration ranges of [1-3H]geranyl diphosphate (GPP), [1-3H]-farnesyl diphosphate (FPP), and [1-3H]-GGPP (American
Radiolabeled Chemicals, Inc.) were adjusted accordingly. Reactions were initiated by adding
enzyme at 30 °C, and quenched with 30 µL 0.5 M ethylenediaminetetraacetic acid (EDTA). A 1mL aliquot of hexane was used to extract hydrocarbon products twice with vigorous vortexing
and subsequently loaded onto a 1-mL silica gel column. The column was washed with 2 mL
hexane and 1 mL ethyl ether. Eluate was collected and radioactivity counts were determined
using a Beckman liquid scintillation counter. Control experiments were performed to determine
background counts. Data were processed with Prism software.
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To characterize chain elongation activity, assays with full-length D92A PaFS or PaFSCT
on a 100-µL scale were conducted in triplicate by the method of Holloway and Popjak with slight
modifications (Holloway and Popjak, 1967). Full-length D92A PaFS was completely inactive
when incubated with GGPP and IPP, as expected. The concentration of [4-14C]-IPP (American
Radiolabeled Chemicals, Inc.) was fixed at 50 µM, and concentrations of DMAPP, GPP, and FPP
were adjusted accordingly to determine the kinetics of chain elongation activity starting with 5-,
10-, and 15-carbon isoprenoid diphosphate substrates, respectively. Briefly, reactions were
initiated by adding enzyme at 30 °C, and quenched with 10 µL 6 M HCl. Newly generated prenyl
diphosphate products were acid-hydrolyzed at 37 °C for 30 min, and subsequently neutralized
with 16 µL of 5.5 M NaOH. The resulting prenyl alcohol was extracted with 1 mL hexane twice
by vigorous vortexing, and was transferred into scintillation vials to determine radioactivity
counts. Background readings were subtracted by conducting control experiments.
The overall catalytic activity for chain elongation and cyclization catalyzed by full-length
PaFS was assessed using substrates DMAPP and [4-14C]-IPP. The concentration of [4-14C]-IPP
was maintained at 50 µM, and that of DMAPP ranged from 3.4 µM to 26.9 µM. Reactions on a
100-µL scale using 1.49 µM of full-length PaFS were conducted at 30 °C, and quenched with 30
µL of 0.5 M EDTA, in triplicate. Hydrocarbon products were extracted with 1 mL hexane twice,
and subsequently transferred to scintillation vials for radioactivity counting, with background
readings subtracted.
Product assays were carried out in duplicate on a 5-mL scale using a previouslydescribed method, slightly modified to minimize the loss of volatile products (Li et al., 2014).
Reactions were initiated at room temperature by adding enzyme into assay buffer containing
substrate (GPP, FPP, or GGPP) overlaid with 5 mL n-pentane. After quenching by EDTA after
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18-20 h of reaction, hydrocarbon products were extracted from the reaction mixture with three
portions of n-pentane and the extracts run through anhydrous MgSO4 to eliminate trace amounts
of water. Samples were then concentrated under vacuum in an ice water bath using a rotary
evaporator and analyzed by gas chromatography-mass spectrometry (GC-MS).
GC−MS analyses were performed using an Agilent 5977A Series GC/MSD instrument
(70 eV, electron impact), a 1 mL injection volume, and a 3 min solvent delay. GC−MS conditions
used a temperature program with a 2 min hold at 60 °C, a 20 °C min−1 increment to 280 °C,
followed by a 2 min hold at 280 °C, and a HP-5ms capillary column (0.25 mm ID x 30 m length x
0.25 mm film, Agilent Technologies). Comparison of GC−MS detected compounds to their
standards was done using the MassFinder 4.2.1 program (http://www.massfinder.com). Retention
indices of compounds were measured using C8-C20 and C10-C40 alkane standards.
Sedimentation equilibrium experiments. To determine the molecular weight of the
intact PaFS oligomer, sedimentation equilibrium experiments were performed using an XL-A
analytical ultracentrifuge (Beckman-Coulter). Two buffer conditions were used: 50 mM Tris (pH
8.5), 200 mM NaCl, 3 mM TCEP; and 10 mM Tris (pH 7.9), 200 mM NaCl, 3 mM TCEP.
Sedimentation equilibrium data were collected at 4°C with absorbance detection at 280 nm for 1–
3 sample concentrations in separate experiments run at 6,000 rpm (2898 x g) and 9,000 rpm
(6520 x g). Data analysis was performed with HeteroAnalysis; data were fit using an ideal singlespecies model at two speeds for each concentration.
Small-angle X-ray scattering (SAXS). X-ray scattering data were collected at the
SIBYLS beamline at the Advanced Light Source (Berkeley, CA, USA) (Hura et al., 2009;
Putnam et al., 2007). Full-length PaFS exhibited undesirable aggregation behavior in solution, so
we collected data from N333A/Q336A PaFS which was better behaved. A 3.3 mg/mL sample of
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full-length N333A/Q336A PaFS in buffer [50 mM Tris (pH 8.5), 200 mM NaCl, 3 mM TCEP,
and 5% glycerol] was exposed for 0.5 second at 283 K. Scattering from a matching buffer
solution was subtracted from the data, and corrected for the incident intensity of X-rays. Data
quality examination and further analyses were performed with PRIMUS and GNOM (Konarev et
al., 2003; Semenyuk and Svergun, 1991). The de novo molecular envelope was calculated with
GASBOR; since the initial envelope displayed prominent three-fold symmetry, three-fold
averaging was imposed (Svergun et al., 2001). Positioning of the molecular model was performed
with SASREF using crystallographic dimers or hexamers of PaFSCT and crystallographic dimers
or monomers of PaFS344 and PaFSCT as described in the text (Petoukhov and Svergun, 2005). The
molecular weight of 524 kD derived from I(0) corresponds most closely to a hexamer (Mr = 502
kD), consistent with the hexameric quaternary structure determined for full-length PaFS using
analytical ultracentrifugation (Figure 5.12). Data collection statistics for SAXS experiments are
recorded in Table 5.2.

112

Table 5.1. Crystallographic data collection and refinement statistics of PaFS
Complex
Resolution limits (Å)
Space group
Unit cell parameters
a, b, c (Å)
α, β, γ (˚)
Total/unique reflections
Twin fraction
Rmergea,b
Rmeasa,c
Rpima,d
CC1/2a,e
I/σ(I)a
Redundancy
Completeness (%)a
Reflections used in
work set/test set
Rworkf
Rfreef
Protein atomsg
Ligand atomsg
Co2+ ionsg
Mn2+ ionsg
Mg2+ ionsg
Cl- ionsg
Solvent atomsg
R.m.s. deviations
Bonds (Å)
Angles (˚)
Average B factors (Å2)
Main chain
Side chain
Solvent
Ligand
Ramachandran Plot(%)
Allowed
Additionally allowed
Generously allowed
Disallowed

103264/32406
0.0
0.153 (0.621)
0.175 (0.743)
0.083 (0.394)
0.950 (0.717)
12.4 (1.3)
3.2 (2.7)
95.2 (94.6)
32390/1626

PaFSCT-Co2+3pamidronate
50.0-2.55
C2221
103.6, 216.1,
129.2
90, 90, 90
536690/47383
0.0
0.120 (0.676)
0.123 (0.738)
0.036 (0.286)
0.986 (0.825)
21.0 (2.0)
11.3 (5.7)
99.5 (95.5)
47336/2389

0.223
0.276
4635
0
0
0
0
0
89

0.214
0.256
7206
39
12
0
0
0
140

0.005
0.9

0.005
0.9

63
67
62
---

55
58
49
63

93.8
5.6
0.6
0.0

93.3
6.5
0.1
0.0

PaFSCT
(unliganded)
50.0-2.43
P321
104.9, 104.9, 140.5
90, 90, 120
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Complex
Resolution limits (Å)
Space group
Unit cell parameters
a, b, c (Å)
α, β, γ (˚)
Total/unique reflections
Twin fraction
Rmergea,b
Rmeasa,c
Rpima,d
CC1/2a,e
I/σ(I)a
Redundancy
Completeness (%)a
Reflections used in
work set/test set
Rworkf
Rfreef
Protein atomsg
Ligand atomsg
Co2+ ionsg
Mn2+ ionsg
Mg2+ ionsg
Cl- ionsg
Solvent atomsg
R.m.s. deviations
Bonds (Å)
Angles (˚)
Average B factors (Å2)
Main chain
Side chain
Solvent
Ligand
Ramachandran Plot(%)
Allowed
Additionally allowed
Generously allowed
Disallowed

PaFS344-Mn2+3neridonate
43.4-2.50
P3221
142.6, 142.6, 117.6
90, 90, 120

PaFS344-Mg2+3pamidronate
50.0-2.30
P3221
143.3, 143.3, 118.3
90, 90, 120

402988/48128
0.22
0.106 (---)h
0.113 (---)h
0.043 (0.656)
0.863 (0.489)
30.0 (1.1)
8.4 (8.3)
100.0 (100.0)
48098/2383

1186692/62273
0.41
0.101 (---)h
0.104 (---)h
0.029 (0.453)
0.967 (0.636)
37.2 (1.3)
19.1 (12.8)
99.9 (99.6)
62219/3177

0.207
0.238
4853
32
0
9
0
2
76

0.178
0.206
5002
26
0
0
6
2
185

0.012
1.3

0.004
0.9

69
74
72
72

57
62
57
59

88.9
11.1
0.0
0.0

89.9
9.9
0.2
0.0

a

Numbers in parentheses refer to the highest resolution shell of data.
Rmerge for replicate reflections, R = ∑|Ih – 〈Ih〉|/∑〈Ih〉; Ih = intensity measure for reflection h; and
〈Ih〉 = average intensity for reflection h calculated from replicate data.
c
Rmeas= ∑[n/(n-1)]1/2|Ih – 〈Ih〉|/∑〈Ih〉; n is the number of observations (redundancy).
b
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d

Rpim= ∑[1/(n-1)]1/2|Ih – 〈Ih〉|/∑〈Ih〉; n is the number of observations (redundancy).
CC1/2 = σ 2/(σ 2 + σ 2), where σ 2 is the true measurement error variance and σ 2 is the independent
measurement error variance.
f
Rwork = ∑||Fo| – |Fc||/∑|Fo| for reflections contained in the working set. Rfree = ∑||Fo| – |Fc||/∑|Fo|
for reflections contained in the test set. |Fo| and |Fc| are the observed and calculated structure
factor amplitudes, respectively.
g
Per asymmetric unit.
h
Rmerge and Rmeas values higher than 1.000 are reported as 0.000 by HKL2000; this is sometimes
observed for datasets with high redundancy.
e

τ

τ

ε

τ

ε
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Table 5.2. SAXS data collection statistics and structural parameters
Full-length N333A/Q336A
PaFS
Data collection
Instrument
Defining slits size
(H mm x V mm)
Detector distance (m)
Wavelength (Å)
q range (Å-1)
Exposure time (s)
Temperature (K)
Structural parameters
I(0) (cm-1) from Guinier plot
Rg (Å) from Guinier plot
I(0) (cm-1) from P(r)
Rg (Å) from P(r)
Dmax (Å) from P(r)
Porod volume (Å3) from
PRIMUS

SIBYLS 12.3.1
4x1
1.5
1.03
0.008–0.55
0.5
283
2072
53.7
2051
52.5
155.4
931501
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Results And Discussion
Catalytic activity of full-length PaFS. Saturation kinetics are not observed for the
generation of diterpene products from the C5 substrates DMAPP and IPP by full-length PaFS.
Interestingly, full-length PaFS exhibits approximately twice the activity at higher DMAPP
concentrations compared with a reconstituted equimolar mixture of the full-length but partially
inactivated mutants D92A PaFS and D474A PaFS, in which the cyclase and GGPP synthase
domains, respectively, have been deactivated (Figure 5.2). Covalent connection of the GGPP
synthase and the GGPP cyclase domains affords a modest enhancement in the rate of formation
of cyclic diterpenes, but this effect is not sufficiently large to suggest product channeling between
active sites.
Full-length PaFS exhibits a sigmoidal dependence of reaction rate on substrate
concentration for the direct cyclization of GGPP with a Hill coefficient of 2.2, with substrate
inhibition being observed at higher GGPP concentrations (Figure 5.3a, Table 5.3). Thus, fulllength PaFS is an allosteric enzyme for GGPP cyclization. When incubated with GGPP, fulllength PaFS generates 64% fusicoccadiene, 9% δ-araneosene, and one additional unidentified
diterpene product.
In the absence of IPP, full-length PaFS can also solvolyze the shorter chain FPP and GPP
as alternative substrates (Figure 5.3) to yield predominantly acyclic products (Figure 5.4): FPP is
converted to farnesol (60.5%), nerolidol (14.0%), and farnesene (14.0%), while GPP is converted
to a mixture of geraniol (59.5%) and linalool (35.0%). The binding of smaller C10 or C15
substrates in the active site of the N-terminal cyclase domain presumably allows binding of water
in the vacant portion of the active site normally occupied by the olefinic tail of the C20 GGPP
substrate, thereby resulting primarily in formation of the derived acyclic allylic alcohols, with
some competing deprotonation in the case of FPP. Finally, the cyclase-catalyzed solvolysis of
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FPP exhibits cooperativity, with a Hill coefficient of 3.0, while the reaction of GPP does not
(Figure 5.3).
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Figure 5.2. Full-length PaFS accelerates the 2-step catalysis by 2 fold. Dependence of the rate of
diterpene generation on DMAPP concentration as catalyzed by 1.49 µM full-length wild-type
PaFS, and 2.03 µM D92A PaFS and D474A PaFS (normalized to wild-type PaFS concentration).
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Figure 5.3. PaFS catalytic activity measurements. (a) Generation of hydrocarbon products from
substrates GPP, FPP, and GGPP in the absence of IPP (the concentrations of full-length PaFS in
these experiments were 74.5 nM, 7.45 nM, and 14.9 nM, respectively). Catalysis with GPP
exhibits Michaelis-Menten kinetics, whereas catalysis with FPP or GGPP exhibits cooperativity
based on the sigmoidal dependence of catalytic activity on substrate concentration. With GGPP,
substrate inhibition is evident at higher concentrations. (b) PaFS350 (33.5 nM) exhibits Michaelis120

Menten kinetics for the generation of hydrocarbon products from substrates GPP, FPP, and
GGPP. (c) Proposed cyclization mechanism29 for the generation of fusicoccadiene (black and blue
arrows) and δ-araneosene (black and red arrows) by full-length PaFS and PaFS350 (a third,
unidentified diterpene product is also generated).
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Catalytic activity of PaFS350. The N-terminal cyclase domain construct PaFS350 is
catalytically active, but the absence of the C-terminal domain presumably results in subtle
structural changes in the N-terminal domain that impact substrate binding and increase the Km,
giving rise to moderate reductions in catalytic efficiency, kcat/Km (Table 5.3). The same trend is
observed with PaFS350 as with full-length PaFS, in that the catalytic efficiency (kcat/Km) of the
reaction with GGPP is lower than that with FPP. In contrast to the behavior of full-length PaFS,
reactions catalyzed by PaFS350 using substrates GPP, FPP, and GGPP exhibit classical MichaelisMenten kinetics, with no evidence of cooperativity (Figure 5.3b). Therefore, the C-terminal
domains are required for allosteric communication among N-terminal domain subunits of the fulllength enzyme.
When incubated with GGPP, PaFS350 generates a mixture of cyclic diterpenes consisting
of 66% fusicoccadiene, 4% δ-araneosene, and one unidentified diterpene product, comparable to
the product array of full-length PaFS (Figure 5.3c). By contrast, when incubated with the
corresponding monoterpene and sesquiterpene analogues, PaFS350 converts GPP exclusively to a
mixture of acyclic monoterpenes consisting predominantly of geraniol (64.5%) and linalool
(28.5%), while FPP is converted to a mixture comprising mostly farnesene isomers (60.2%) and
nerolidol (9.5%) (Figure 5.4). Compared with full-length PaFS, the truncation mutant PaFS350
essentially lost the ability to convert FPP into farnesol (1.0%), instead favoring deprotonation of
the farnesyl cation to produce acyclic farnesene hydrocarbons. Subtle structural changes in the
active site presumably caused by the domain truncation may lead to the observed alteration in
product outcome. Alternatively, it is also possible that the C-terminal elongation domain in fulllength PaFS makes some contribution to the catalytic solvolysis of FPP in the absence of IPP.
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Table 5.3. Catalytic activity of PaFS constructs

Full-length PaFS
Substrate

kcat (s-1)

Km (µM)

kcat/Km (M-1s-1)

h

GPPa

0.036 ± 0.007

9.2 ± 2.6

3.9 x 103

1.0

FPPb

0.027 ± 0.001

0.14 ± 0.02

1.9 x 105

3.0

GGPPc

0.021 ± 0.002

0.63 ± 0.03

3.3 x 104

2.2

Cyclization domain, PaFS350
Substrate

kcat (s-1)

Km (µM)

kcat/Km (M-1s-1)

h

GPPa

0.0036 ±
0.0005

1.5 ± 0.6

2.7 x 103

1.0

FPPd

0.069 ± 0.004

1.5 ± 0.3

4.6 x 104

1.0

GGPPc

0.0042 ±
0.0002

9.6 ± 1.1

4.4 x 102

1.0

Substrates for
GGPP
biosynthesis

Full-length D92A PaFS, with inactivated
cyclase domain
kcat (s-1)

Km (µM)

kcat/Km (M-1s-1)

GPP + IPP

0.26 ± 0.03

2.1 ± 0.6

1.2 x 105

FPP + IPP

1.6 ± 0.2

1.9 ± 0.5

8.4 x 105

a

GGPP synthase
domain, PaFSCT
specific activity
(nmol•s-1mg-1)
0.77 ± 0.03
1.96 ± 0.08

Yields geraniol and linalool as major products. bYields (E,E)-farnesol and (E)-nerolidol as major
products. cYields fusicoccadiene, δ-araneosene, and one unidentified diterpene as major products.
d
Yields (E)-β-farnesene and (E)-nerolidol as major products.
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OPP

OPP

GPP

FPP

trans geranyl cation cis geranyl cation

trans farnesyl cation

cis farnesyl cation

OH
OH

geraniol
(59.5%)
(64.5%)

allo-ocimene
(0.5%)
(0.5%)

(E,E)-farnesol
(60.5%)
(1.0%)

(Z)-β-ocimene
(2.5%)
(4.0%)

OH

H

(E)-β-caryophyllene α-humulene
(0.5%)
(1.0%)
(0.8%)
(3.6%)

OH

OH

linalool
(35.0%)
(28.5%)

H

(Z)-γ-bisabolene
(1.0%)
(0.6%)

(E)-α-bisabolene
(1.0%)
(0.8%)

(E)-nerolidol
(14.0%)
(9.5%)

α-terpineol
(2.5%)
(2.5%)
β-elemene*
(1.0%)
(0.0%)
*thermal
rearrangement
product from
germacrene A.

(E)-β-farnesene
(14.0%)
(50.7%)

(E,E)-α-farnesene
(0.0%)
(9.5%)
O

(E,E)-farnesal
(1.0%)
(3.5%)

β-acoradiebe
(1.0%)
(0.0%)

Plus 5 unidentified sesquiterpenes comprising 5% of the total
for full-length PaFS.
Plus 5 unidentified sesquiterpenes comprising 20% of the total
for PaFS 350.

Figure 5.4. Product arrays generated by full-length PaFS (black) and PsFS350 (red) for cyclization
reactions utilizing GPP and FPP as substrates. The presence of trace amounts of (E,E)-farnesal in
assays with FPP likely results from an aberrant oxidation reaction with (E,E)-farnesol, perhaps
catalyzed by trace amounts of an E. coli alcohol dehydrogenase impurity in the protein samples.
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Table 5.4. Protein-metal ion interactions in PaFSCT and PaFS344

PaFSCT-Co2+3-Pamidronate Complex
Co2+-Ligand Distances (Å)
D474 OD2
Pamidronate O10
D478 OD2
w1
w2
w3

Co2+C
2.0
2.1
2.1
1.9
2.0
2.0

D478 OD2
Pamidronate O3
Pamidronate O10
D474 OD1
w1
w2

Co2+A
2.2
2.0
2.0
2.0
2.0
2.3

Pamidronate O5
Pamidronate O12
D605 OD2
w1
w2
w3

Co2+B
2.0
1.9
2.1
2.0
2.0
2.3

PaFS344-Mn2+3-Neridonate Complex
Mn2+-Ligand Distances (Å)
D92 OD2
Neridronate O3
D96 OD2
w1
w2
w3
w4

Mn2+C
1.9
2.6
1.9
1.8
1.8
2.4
2.0

D96 OD2
Neridronate O3
Neridronate O10
D92 OD1
w1
w2

Mn2+A
2.7
1.8
1.7
2.1
1.8
2.2

Neridronate O2
Neridronate O9
S236 OG
N232 OD1
E240 OE2
E240 OE1
w1

Mn2+B
2.1
1.9
2.3
2.0
2.2
2.3
2.0

PaFS344-Mg2+3-Pamidronate Complex
Mg2+-Ligand Distances (Å)
D92 OD2
Pamidronate O3
D96 OD2
w1
w2
w3

Mg2+C
2.1
2.6
2.4
1.9
2.3
2.4

D96 OD2
Pamidronate O3
Pamidronate O10
D92 OD1
w1
w2
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Mg2+A
2.6
1.7
2.1
2.0
2.2
2.3

Pamidronate O2
Pamidronate O9
OG S236
OD1 N232
OE2 E240
w1

Mg2+B
2.4
2.3
2.3
2.2
1.9
1.9

Catalytic activity of PaFSCT. The measurement of steady-state kinetic parameters for the
chain elongation reaction was complicated by the existence of an ambiguous mixture of
oligomeric species detected for the C-terminal domain construct PaFSCT. Accordingly, we
measured only the specific activity of PaFSCT (Table 5.3).
To measure the steady-state kinetic parameters in full-length PaFS for the chain
elongation reaction catalyzed exclusively by the C-terminal domain, the N-terminal cyclization
domain was inactivated by the D92A mutation, which abolished the binding of catalytically
essential Mg2+ ions. As expected, the resultant D92A PaFS did not generate any cyclic products
yet retained GGPP synthase activity. The chain elongation reaction in the D92A mutant using the
5-carbon substrates DMAPP and IPP was extremely sluggish, however, thereby preventing
determination of the steady-state kinetic parameters. In contrast, GPP and FPP were processed
with increasing efficiency when co-incubated with IPP to generate GGPP (Table 5.3). This result
presumably reflects the imperative for GGPP biosynthesis by this processive enzyme, in that the
product of one cycle of chain elongation generates a better substrate for the next cycle of chain
elongation until the isoprenoid chain length reaches the maximum limit set by the depth of the
active site cavity.
Crystal structure of PaFSCT. Crystals of the unliganded and liganded GGPP synthase
domain PaFSCT belong to two distinct space groups (Table 5.1). Regardless of the presence or
absence of ligand, both crystal forms reveal a hexameric quaternary structure in the crystal lattice
(Figure 5.5a). The hexamer can also be described as a trimer of isologous dimers with D3 point
group symmetry. Extensive surface area is buried between each monomer of the dimer (1,854 Å2
per monomer), and between one dimer and the next (1,960 Å2 per dimer), as calculated by PISA
(http://www.ebi.ac.uk/pdbe/pisa). The active site of each monomer is oriented inward toward a
central cavity approximately 22 Å in diameter. Helices B, E, and F of each monomer mediate
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dimer assembly, in similar fashion to that first observed in the avian FPP synthase dimer (Figure
5.6) (Tarshis et al., 1994). With regard to dimer-dimer interactions in hexamer assembly, helices
α2 and α3 of one dimer engage loops connecting helices D and E of one monomer and helices F
and G of the other monomer in the neighboring dimer. While similar quaternary structure is
observed for human GGPP synthase (Kavanagh et al., 2006), GGPP synthases from yeast and
mustard crystallize simply as isologous dimers (Chang et al., 2006; Kloer et al., 2006).
The structure of the PaFSCT monomer clearly reveals the characteristic class I terpenoid
synthase fold (Figure 5.5b). Like other class I terpenoid synthases (Christianson, 2006), PaFSCT
undergoes a significant conformational change upon the binding of ligands. In unliganded PaFSCT,
the α1 loop is disordered. This loop flanks the ~14 Å-deep active site cleft, the contour of which
is defined mainly by nonpolar residues. In the liganded enzyme, the a1 loop becomes ordered and
α-helices D, H, and α3 shift to fully enclose the active site. The substrate analogue pamidronate
(Figure 5.7) binds in the DMAPP binding site, and the bisphosphonate moiety of pamidronate
mimics the diphosphate moiety of DMAPP (as inhibitors of human FPP synthase,
bisphosphonates are formulated as drugs such as Fosamax to treat osteoporosis) (Ezra and
Golomb, 2000). The bisphosphonate moiety of pamidronate coordinates to 3 Co2+ ions, which are
also coordinated by two aspartate-rich metal binding motifs, D474DFQD and D605DYQN on
helices D and H, respectively (Figure 5.5 and Figure 5.8a). Water molecules complete metal
coordination polyhedra so that each metal ion is 6-coordinate with octahedral geometry. The
bisphosphonate moiety is also stabilized by hydrogen bonds with R483, K619, and K629; an
additional hydrogen bond is made with K561 in some monomers. Typically, diphosphate or
bisphosphonate binding to terpenoid synthases is accommodated by 3 metal ions and 3 basic
residues, and these interactions ensure complete active site closure (Aaron and Christianson,
2010).
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Figure 5.5. PaFS C-terminal GGPP synthase domain. (a) PaFSCT adopts the a fold of a class I
terpenoid synthase and crystallizes as a hexamer, or a trimer of dimers. The N-termini of selected
subunits are labeled and indicate the point of connection to the missing N-terminal domain. Two
perpendicular orientations are shown. (b) The binding of 3 Co2+ ions and pamidronate triggers
complete closure of the active site of PaFSCT. (c) Stereoview of intermolecular interactions in the
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PaFSCT-Co2+3-pamidronate complex. Metal coordination and hydrogen bond interactions are
shown as black and red dashed lines, respectively (metal-ligand distances are recorded in
Supplementary Information Table S3). Pamidronate binds in the DMAPP binding site, so
interactions of the phosphonate groups mimic interactions with the diphosphate group of DMAPP
that trigger ionization and formation of the allylic cation that initiates the chain elongation
reaction.
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Figure 5.6. Comparison of PaFSCT dimer architecture (left) with that of avian farnesyl
diphosphate synthase (right; PDB 1FPS). Selected helices in PaFSCT are labeled as discussed in
the text.

130

Pamidronate

–O
–O

O

O

P

P

O–
O–

HO

Neridronate

–O
–O

O

O

P

P

O–
O–

HO
NH 3+

+H

3N

Figure 5.7. Molecular structures of the bisphosphonate substrate analogues used in the current
study.
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Figure 5.8. Zoom-in view of metal coordination in elongation and cyclization active site. (a)
Omit maps of Co2+ ions (contoured at 18.5σ) and pamidronate (contoured at 4.5σ) in the PaFSCTCo2+3-pamidronate complex. The pendant alkylamino group of pamidronate is partially
disordered in the active site cavity. (b) Omit maps of Mn2+ ions (contoured at 10.5σ) and
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neridronate (contoured at 4.5σ) in the PaFS344-Mn2+3-neridronate complex. The pendant
alkylamino group of neridronate is disordered in the active site cavity. (c) Omit maps of Mg2+
ions (contoured at 6.2σ) and pamidronate (contoured at 4.5σ) in the PaFS344-Mg2+3-pamidronate
complex. The pendant alkylamino group of pamidronate is partially disordered in the active site
cavity.
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Crystal structure of PaFS344. Crystallization of the GGPP cyclization domain PaFS344
complexed with 3 Mn2+ ions and the bisphosphonate substrate analogue neridronate (Figure 5.9)
was achieved by in situ proteolysis. Crystals diffracted X-rays to 2.5 Å resolution and were
moderately twinned (22%). The initial electron density map was phased using the singlewavelength anomalous diffraction of the Mn2+ ions. The refined structure of the PaFS344-Mn2+3neridronate complex (Figures 5.8b and 5.10) then facilitated structure determination of the
PaFS344-Mg2+3-pamidronate complex (Figure 5.9 and Figure 5.8c) from highly twinned crystals
(41%) using molecular replacement. Since Mg2+ is generally the metal ion required by terpenoid
cyclases in vivo, this structure with its 3 bound Mg2+ ions is more biologically relevant.
Two monomers oriented in antiparallel fashion occupy the asymmetric unit of PaFS344
crystals, and these monomers interact through 583 Å2 of contact surface area (calculated with
PISA). This relatively minimal buried surface area suggests that PaFS344 is a monomer in solution,
consistent with the results of gel filtration chromatography. Like PaFSCT, the PaFS344 monomer
adopts the characteristic class I terpenoid synthase fold (Figure 5.9a). However, two extra
segments in PaFS344, E2-T16 at the N-terminus and P328-L344 at the C-terminus, are fully
ordered and distinguish PaFS344 from PaFSCT. The active site of PaFS344 is locked in a fully
closed conformation through the binding of 3 Mn2+ ions and neridronate (Figures 5.8b and 5.10).
The Mn2+ ions are also coordinated by the aspartate-rich metal binding motif (D92DVTD96) on
helix D as well as the "NSE" motif (N232DIWS236WPKE240) on helix H. Water molecules
complete metal coordination polyhedra so that each metal ion is 6-coordinate with octahedral or
distorted octahedral geometry. Additionally, the bisphosphonate moiety receives hydrogen bonds
from R188, K239, R325, and Y326. Thus, as observed in PaFSCT, 3 metal ions and 3 basic
residues ensure the molecular recognition of the bisphosphonate moiety, and these interactions
ensure complete active site closure.
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The higher resolution structure (2.3 Å) of the PaFS344-Mg2+3-pamidronate complex
determined from highly twinned crystals is generally identical to that of the PaFS344-Mn2+3neridronate complex, with an r.m.s. deviation of 0.28 Å for 273 Ca atoms. The Mg2+ coordination
polyhedra in this structure (Figure 5.9 and Figure 5.8c) are essentially identical to Mn2+
coordination polyhedra (Figure 5.10), suggesting that these two metal ions may be
interchangeable for function. Additionally, hydrogen bond interactions with the bisphosphonate
groups of pamidronate and neridronate are essentially identical in both structures.
While the N- and C-terminal domains of PaFS exhibit 19% mutual amino acid sequence
identity, it is interesting that PaFS344 exhibits a higher sequence identity (24%) with the fungal
sesquiterpene cyclase aristolochene synthase from Penicillium roqueforti. In fact, this is the
highest sequence identity shared between PaFS344 and any terpenoid synthase, the next highest
being with aristolochene synthase from the orthologous Aspergillus terreus, with which it shares
22% sequence identity. A search of available terpenoid cyclase structures using Dali indicates
that PaFS344 most closely resembles aristolochene synthase from A. terreus (Z = 25.7, root-meansquare deviation (rmsd) = 2.5 Å for 257 Cα atoms) (Holm and Rosenstrom, 2010). Among
diterpene cyclases, PaFS344 most closely resembles the bacterial cyclase CotB2 (Z = 15.7, rmsd =
3.3 Å for 221 Cα atoms) (Janke et al., 2014), although the amino acid sequence identity between
these two proteins is only 14%. PaFS344 exhibits comparable structural similarity with the α
domain of taxadiene synthase from the Pacific yew (Z = 15.6, rmsd = 3.3 Å for 236 Cα atoms) as
well as fungal ent-kaurene synthase (Z = 15.6, rmsd = 3.2 Å for 217 Cα atoms) (Koksal et al.,
2011; Liu et al., 2014). Therefore, the diterpene cyclase domain of PaFS is more similar to
sesquiterpene cyclases than to diterpene cyclases based on both sequence and structural
comparisons.
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A feature that distinguishes PaFS344 from other terpenoid cyclases is the T58–F65 loop,
which mediates a direct connection between the cyclase active site and the polypeptide linker
segment D329–S389 that connects the C-terminal GGPP synthase domain and the N-terminal
cyclase domain in full-length PaFS. Main chain atoms of the G60–P61 segment at the tip of this
loop make hydrogen bonds with the side chains of N333 and Q336 in the D329–L344 fragment of
the linker segment (D329–S389) present in the PaFS344 construct (Figure 5.9). Additionally, the
main chain NH group of G60 hydrogen bonds with S64, which is immediately adjacent to F65,
the ring face of which partially defines the active site contour. Given that the linker segment
connecting the catalytic domains in full-length PaFS is about 60 residues long, it is possible that
in addition to direct domain-domain interactions, the linker could transmit interdomain as well as
intrasubunit conformational changes between active sites to enable cooperativity in catalysis. The
functional importance of interdomain linkers in this regard has been reviewed by Ma and
colleagues (Ma et al., 2011).
Highly reactive carbocation intermediates in the cyclization cascade require not only a
fully enclosed active site for protection from bulk solvent, but they also require a chemically inert
active site capable of stabilizing these high-energy intermediates and their intervening transition
states. To better understand how the cyclization domain of PaFS enables this chemistry, a model
of the product fusicoccadiene docked in the active site of PaFS344 was generated (Figures
5.11a,b). The ring faces of aromatic residues F65, F89, and W197 appear to be ideally positioned
to stabilize proposed carbocation centers through cation-π interactions (Toyomasu et al., 2009).
Additionally, the structure of PaFS344 reveals a characteristic break in helix G at the V192-G193
segment with the C-terminal end of helix G1 oriented toward the active site. The best fit of
fusicoccadiene in the active site is such that sites of developing positive charge on the face of the
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macrocycle are oriented toward the backbone carbonyl of V192, consistent with possible
carbocation stabilization by the helix G1 macrodipole (Baer et al., 2014).
Given the general lack of acidic or basic residues in the PaFS344 active site cavity, it is
possible that inorganic pyrophosphate (PPi) serves as a general base to quench the final
carbocation intermediate to yield fusicoccadiene (Figure 5.3). A similar role for the PPi coproduct was first considered in the aristolochene synthase mechanism and subsequently in the
FPP synthase mechanism (Hosfield et al., 2004). As docked in the active site of PaFS344, the
correct end of the 5-8-5 carbon skeleton is oriented toward the PPi-Mg2+3 cluster so as to enable a
final PPi-mediated deprotonation to generate fusicoccadiene (Figures 5.11a,b). The PPi anion
could similarly mediate the final deprotonation that generates the minor product δ-araneosene.
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Figure 5.9. PaFS N-terminal GGPP cyclase domain. (a) Stereoview of the PaFS344-Mg2+3pamidronate complex reveals that the N-terminal domain adopts the α fold of a class I terpenoid
synthase. (b) Stereoview of the PaFS344-Mg2+3-pamidronate complex showing metal coordination
and hydrogen bond interactions as black and red dashed lines, respectively (metal-ligand
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distances are recorded in Table 5.4). (c) The G60-F65 hairpin segment may facilitate
communication between cyclization domain active sites in full-length hexameric PaFS by
mediating interactions between active site residue F65 and interdomain linker residues N333 and
Q336 (green).
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Figure 5.10. Stereoview of the PaFS344-Mn2+3-neridronate complex. Metal coordination and
hydrogen bond interactions are shown as black and red dashed lines, respectively (metal-ligand
distances are recorded in Table 5.4).
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Figure 5.11. Models of PaFS enzyme-product complexes. (a) Model of product fusicoccadiene
bound in the active site of PaFS344. The three-dimensional active site contour is represented by
black meshwork, and fusicoccadiene was manually fit into this meshwork. The position of the
Mg2+3-PPi cluster is modeled after the Mg2+3-bisphosphonate cluster in the PaFS344-Mg2+3pamidronate complex. Two perpendicular views are shown; the backbone carbonyl of V192 at the
helix G break (δ–) is oriented toward the location of a proposed carbocation intermediate in the
PaFS mechanism. (b) Cut-away view of the active site pocket of PaFS344, showing how the
surface contour (black meshwork) is defined by residues lining the pocket. (c) Ophiobolin F
docked in the active site of ophiobolin F synthase modeled after the PaFS344-fusicoccadiene
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complex in (b). The extra active site volume resulting from the W225L and V228A substitutions
readily accommodate the larger C25 sesterterpene.
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Hexameric quaternary structure of PaFS. Gel filtration chromatography initially
indicated that full-length PaFS is an oligomer with either 5 or 6 subunits; analytical
ultracentrifugation experiments confirmed that full-length PaFS is a 502-kD hexamer (Figure
5.12). Therefore, small-angle X-ray scattering (SAXS) was used to view the molecular envelope
and determine the molecular dimensions of PaFS in solution. The radius of gyration (Rg) from
Guinier analysis of low-angle scattering data is 53.7 Å, and the pair-distance distribution function
P(r) yields an Rg value of 52.5 Å and a maximum dimension (Dmax) value of 155.4 Å (Figure
5.14). These dimensions are consistent with the assembly of the full-length protein as a hexamer.
Upon initial inspection of the ab initio molecular envelope of PaFS calculated from
SAXS data (Figure 5.13), it was evident that the hexameric architecture of PaFSCT docked with 3
PaFS344 dimers would not fit satisfactorily within this envelope. Indeed, our best attempt at
manual fitting in this regard yielded χ = 7.4 (χ is a measure of the goodness of fit of the protein
model to the X-ray scattering data; a lower χ value indicates a better fit). We subsequently
hypothesized that the C-terminal domains observed in the crystal structure of PaFSCT could
dissociate into 3 dimers. Indeed, dimeric quaternary structure is observed for GGPP synthases
from yeast and mustard (Chang et al., 2006; Kloer et al., 2006); the PaFS dimer (Figure 5.6) is
identical to these. Accordingly, to optimize the fit of PaFS domains into the molecular envelope,
we utilized the program SASREF to allow the 3 PaFSCT dimers of the crystallographic hexamer
to separate by 5 Å and reorient by 15° (Petoukhov and Svergun, 2005). Subsequently, 3
PaFS344 crystallographic dimers were docked at the periphery, all while maintaining overall threefold symmetry. The resulting model yielded a satisfactory fit to the molecular envelope with χ =
1.5 (Figure 5.13). The C-terminus of PaFS344 and the N-terminus of PaFSCT are approximately 25
Å apart, suggesting that the flexible 60-residue long linker connecting the C-terminal and Nterminal domains may reside between the PaFSCT and PaFS344 dimers. This would facilitate the
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possible function of the linker in mediating interdomain communication required for allosteric
catalysis.
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Figure 5.12. Full-length PaFS behaves as hexamer in solution. Sedimentation equilibrium runs
with full-length PaFS lasted 24 h at two different speeds indicated. Nonlinear fits of experimental
data yield average molecular weights (Mr) of 523 kD at 6,000 rpm (2898 x g) and 479 kD at
9,000 rpm (6520 x g), each within experimental error (5%) of the calculated molecular weight of
a hexamer (Mr = 502 kD). Residuals are shown below fitted data and indicate a good fit of
equilibrium concentration gradients.
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Figure 5.13. Structure of the full-length PaFS hexamer in solution. (a) Model of the hexamer of
full-length N333A/Q336A PaFS fit into the three-fold averaged ab initio molecular envelope
generated from SAXS data. PaFS344 and PaFSCT dimers are marine and green, respectively. (b)
Theoretical scattering profile (teal solid line) overlaid with experimental data (black) indicates an
excellent fit of the molecular envelope in (a), with χ = 1.5 as calculated with SASREF.
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Figure 5.14. PaFS SAXS parameters. (a) Gunier plot of full-length N333A/Q336A PaFS
generated from SAXS data indicates homogeneity of the protein sample. (b) Pair-distance
distribution function P(r) generated from SAXS data collected from full-length N333A/Q336A
PaFS.
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Implications for bifunctional catalysis. The catalytic efficiencies for the conversion of
GGPP and FPP into hydrocarbon products by full-length PaFS in the absence of IPP are almost
equal, which is curious in view of the fact that until now PaFS was believed to be solely a
diterpene cyclase (Toyomasu et al., 2007). However, if the intracellular and/or local
concentrations of GGPP exceed those of FPP, then aberrant processing of FPP would not be an
issue. It is certainly possible that the coordinate expression and covalent assembly of the GGPP
synthase and cyclase domains ensure a higher local concentration of GGPP so that the cyclization
of GGPP by the N-terminal domain is favored. When full-length PaFS is incubated with DMAPP
and IPP, diterpene products are exclusively generated. Thus, intermediates GPP and FPP do not
dissociate from the C-terminal domain for aberrant reactions with the N-terminal domain.
Interestingly, when full-length PaFS is incubated solely with a 1:1 ratio of FPP and IPP,
the ratio of sesquiterpene to diterpene products generated is 57:43, while with an FPP:IPP ratio of
1:8, the sesquiterpene:diterpene product ratio decreases slightly to 35:65, indicating that the
amount of GGPP produced and cyclized is increased compared with the direct, anomalous
cyclization of FPP. Even so, since FPP is not released from the C-terminal domain during GGPP
biosynthesis from DMAPP and IPP, local concentrations of FPP should remain well below the Km
for FPP utilization by the N-terminal domain, thereby ensuring that the anomalous processing of
FPP by the cyclase domain will be minimal in vivo.
While there does not appear to be strong channeling from the C-terminal domain to the
N-terminal domain, the generation of diterpene products by full-length PaFS is roughly twice as
fast as that observed for an equimolar mixture of two PaFS mutants bearing inactivated chain
elongation and cyclase domains, respectively (Figure 5.2). This is consistent with the similarly
modest enhancement of the rate of sesquiterpene product formation by a bifunctional fusion
protein engineered between farnesyl diphosphate synthase and 5-epi-aristolochene synthase,
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perhaps reflecting a modestly advantageous proximity effect influencing the transient local
concentration of the acyclic intermediate (Brodelius et al., 2002). This modest enhancement could
also reflect the possibility of an agglomeration or enzyme-clustering effect resulting in part from
the hexameric quaternary structure of full-length PaFS (Castellana et al., 2014).
Notable, too, is the fact that PaFS350 is most closely related to the fungal sesquiterpene
cyclase aristolochene synthase (amino acid sequence identities of 24% and 22%, respectively,
with the enzymes from P. roqueforti and A. terreus). In comparison, the amino acid sequence
identity between the N-terminal and C-terminal domains of PaFS is 19%. Thus, the evolutionary
origins of the αα domain architecture of PaFS are not clear, particularly in view of the catalytic
versatility of the cyclase domain with both C15 and C20 substrates. While it is tempting to
speculate that αα domain architecture arose from a gene duplication and fusion event involving a
primordial diterpene synthase, it is also possible that the cyclization domain of PaFS evolved
from an ancestral sesquiterpene synthase, developing the ability to utilize GGPP as well as FPP
subsequent to fusion with a GGPP synthase.
Finally, it is instructive to compare PaFS with the bifunctional sesterterpene cyclase
ophiobolin F synthase from Aspergillus clavatus (AcOS), which generates tricyclic products from
C25 geranylfarnesyl diphosphate, each containing a common 5-8-5 tricyclic ring structure similar
to that of fusicoccadiene (Chiba et al., 2013). The cyclization domains of AcOS and PaFS share
42% amino acid sequence identity, and there is significant conservation of the residues that
contribute to the active site contour in each cyclase. Although most paired residues are isosteric
or strictly conserved, two are smaller: L217 and A220 of AcOS correspond to W225 and V228 of
PaFS, respectively. As a result, the active site of AcOS is slightly larger, so that it can
accommodate the isoprenoid tail of a C25 substrate as distinguished from a C20 substrate. However,
the active site contours are otherwise highly similar (Figure 5.11c), so as to accommodate and
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enforce the cyclization cascade leading to the formation of the 5-8-5 tricyclic product. Future
experiments will probe the role of this contour in PaFS as a specialized template for the
generation of tricyclic 5-8-5 hydrocarbon products.
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Chapter 6: Future Directions
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How Can We Automate Terpene Synthase/Cyclase Annotation and Achieve Precision
Simultaneously?
Knowledge of canonical terpene synthases/cyclases has been advanced greatly in the past
few decades. However, in an era when one out of three protein sequences in NCBI has no
assigned function (Sivashankari and Shanmughavel, 2006) and high-throughput experiments that
are indispensable for accurate annotation are not yet available (Wallrapp et al., 2013), a carefullydesigned metric is necessary for researchers to rate and prioritize their research targets before
they delve into conventional biochemical studies that provides most knowledge but nonetheless
time-consuming and difficult to generalize and automate. Computational approaches, in
combination with downstream ‘omics’ studies, offer the promise of cracking the logic behind
natural product biosynthesis and deciphering their physiological role (Blin et al., 2013; Doroghazi
et al., 2014; Medema et al., 2012; Medema and Fischbach, 2015; Weber et al., 2015). The
ultimate goal of such computational approaches are once genome sequence is made available, a
thorough analysis of genes will provide us an idea of what molecules are synthesized, how they
can serve the organism from both molecular and cellular level, and how they can be translated for
industrial applications (Medema et al., 2011). For example, the present capability of antiSMASH
(Weber et al., 2015), one of the platforms for automating natural product discovery and
characterization, is to predict the core structure of lantipeptides, non-ribosomal peptides, and
polyketides. Given that the biosynthesis of these compounds usually follows modularity rule,
they can serve as starting points for natural product prediction. In stark contrast, terpene
biosynthesis is so diverse that multiple bond breakage and formation takes place in one enzyme
active site and a single residue difference can completely change the cyclization pattern, for
example, as demonstrated for diterpene biosynthesis in Oryza sativa (Morrone et al., 2008; Zi et
al., 2014). Phylogenetic analysis that generally relies on sequence alignment and constitutes a
vital part of automated natural product prediction is insufficient to accurately predict the product
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profile of an unannotated terpenoid cyclase. Protein-ligand docking computational studies have
proven to be effective in addressing the problem (Wallrapp et al., 2013), but developing a fast and
precise prediction platform necessitates a more complete elucidation of terpenoid cyclase
structure–function relationships.
Understanding the Dynamic Nature of Tepene Cyclization
The motivation for understanding mechanism of terpene synthases/cyclases is 2-fold:
First, to elucidate the evolutionary relationship among them; Second, to pinpoint the role of a
specific active site residue plays during catalysis, which eventually enables rational
enzyme/pathway engineering to generate ‘unnatural’ natural products that, for example, can be
used in industrial settings. Classical enzymology studies of terpene cyclases have focused on one
enzyme at a time and are conducted under conditions different from its physiological
environment. The simplified and streamlined study definitely clears out potential interferences,
but it also brings out questions whether or not results obtained in vitro represent what happens in
vivo. Is the enzyme of interest always active or it has to be activated by an upstream signal? Does
it have undiscovered binding partners or cofactors to collaborate with in order to function
properly? What is its activity profile like and how is the activity regulated? On the other hand, the
dynamic nature of enzyme active site that chaperones bond formation and breakage along the
catalysis trajectory remains elusive, and this topic also applies to other enzymes that employ
conformational changes to catalyze reactions (Glowacki et al., 2012; Klinman, 2014; Nagel and
Klinman, 2009). Do active site residues remain static between different stages of catalysis? How
do active site residues communicate with each other to direct carbocation cascade on the right
trajectory? Admittedly, to answer these questions requires progress in computation (such as
increasing the computation efficiency by calculating a longer time frame in shorter time), but it
does not necessarily exclude enzymology from experimental methods. A starting point can be a
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Förster resonance energy transfer (FRET) study that takes advantage of nascent aromatic residues
in the active site and well-estabilished unnatural amino acid substitution technology.
Translating Enzymology into Synthetic Biology
While enzymology deconstructs biosynthetic machineries in a way to understand the
structure-function relationships of an enzyme of interest, synthetic biology rewires and
reprograms necessary enzyme players in a complete biosynthetic pathway to yield high levels of
desired natural products in a cheaper and greener fashion (Khalil and Collins, 2010; Way et al.,
2014). Taking fusicoccin as an example for synthetic biology, if a number of similar biosynthetic
machineries have been identified, do we take all enzymes from the same pathway or we mix and
match? Given that fusicoccadiene synthase is promiscuous in product profile, do we need to make
it high-fidelity by either structure-based engineering or directed evolution? If cotylenin A, one of
its naturally occurring analogues whose hydroxyl group is at the 3-position rather than the 8position, has shown better bioactivity, can we engineer the dioxygenase responsible for
hydroxylating the carboskeleton to change the hydroxylation position? These questions
demonstrate the importance of understanding structure–function relationships of each enzyme
player in a biosynthetic pathway, which is essential for building a microbial factory to generate
high-value terpenoids.
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